<SEC-DOCUMENT>0001193125-24-194475.txt : 20240806
<SEC-HEADER>0001193125-24-194475.hdr.sgml : 20240806
<ACCEPTANCE-DATETIME>20240806090329
ACCESSION NUMBER:		0001193125-24-194475
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20240806
DATE AS OF CHANGE:		20240806
EFFECTIVENESS DATE:		20240806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Summit Therapeutics Inc.
		CENTRAL INDEX KEY:			0001599298
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-281273
		FILM NUMBER:		241177285

	BUSINESS ADDRESS:	
		STREET 1:		2882 SAND HILL ROAD
		STREET 2:		SUITE 106
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-460-8308

	MAIL ADDRESS:	
		STREET 1:		2882 SAND HILL ROAD
		STREET 2:		SUITE 106
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Therapeutics plc
		DATE OF NAME CHANGE:	20150219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Corp plc
		DATE OF NAME CHANGE:	20140205
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d845594ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
<HTML><HEAD>
<TITLE>S-3ASR</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on August&nbsp;6, 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&#8194;&#8194;&#8194;&#8194;&#8194; </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-3</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>Summit Therapeutics Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">37-1979717</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State or Other Jurisdiction of<BR>Incorporation or Organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer<BR>Identification No.)</B></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>601 Brickell Key Drive, Suite 1000 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Miami, FL 33131 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(305) <FONT
STYLE="white-space:nowrap">203-2034</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of
registrant&#146;s principal executive offices) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Robert W. Duggan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Mahkam Zanganeh</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Chairman and Chief Executive Officer</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Chief Executive Officer and President</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Summit Therapeutics Inc.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Summit Therapeutics Inc.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>601 Brickell Key Drive, Suite 1000</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>601 Brickell Key Drive, Suite 1000</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Miami, FL 33131</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Miami, FL 33131</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>(305) <FONT STYLE="white-space:nowrap">203-2034</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(305) <FONT STYLE="white-space:nowrap">203-2034</FONT></B></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>With copies to: </I></B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Adam Finerman, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Baker&nbsp;&amp; Hostetler LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>45 Rockefeller Plaza </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>New
York, NY 10111</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">589-4233</FONT> </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public:</B> From time to time after the effective date of this Registration Statement. </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following
box:&#8194;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:&#8194;&#9746; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If this Form is
a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744;
</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing
with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.&#8194;&#9746; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&#8194;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging growth company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&#8194;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g845594g84l03.jpg" ALT="LOGO" STYLE="width:2.58035in;height:1.64444in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>22,222,222 Shares of Common Stock </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to the proposed resale from time to time by the selling stockholders named herein, together with any of such
stockholders&#146; transferees, pledgees, donees or successors, an aggregate of 22,222,222 shares (the &#147;Shares&#148;) of our common stock, par value $0.01 per share (&#147;common stock&#148;), issued to the selling stockholders pursuant to that
certain securities purchase agreement, dated as of June&nbsp;3, 2024 (the &#147;Purchase Agreement&#148;), by and among us and the selling stockholders (the &#147;Selling Stockholders&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the offer and sale of the Shares from time to time by the Selling Stockholders to satisfy registration rights the Selling
Stockholders were granted in connection with the Purchase Agreement. We are not selling any of our common stock pursuant to this prospectus, and we will not receive any proceeds from the sale of our common stock offered by this prospectus by the
Selling Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may offer and sell or otherwise dispose of the Shares described in this prospectus from
time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. The Selling Stockholders will bear all underwriting fees, commissions and discounts, if
any, attributable to the sales of Shares and any transfer taxes. We will bear all other costs, expenses and fees in connection with the registration of the Shares. See &#147;Plan of Distribution&#148; for more information about how the Selling
Stockholders may sell or dispose of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The Nasdaq Global Market under the trading symbol
&#147;SMMT.&#148; On August&nbsp;5, 2024, the last reported sales price of our common stock on The Nasdaq Global Market was $10.02 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our common stock involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#147;<A HREF="#toc845594_4">Risk Factors</A>&#148; on page&nbsp;7 of this prospectus, and under similar headings in
any amendment or supplement to this prospectus or in the other documents that are incorporated by reference into this prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR
DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is August</B><B></B><B>&nbsp;6, 2024</B>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_2">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_3">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_6">SELLING STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_7">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_8">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_9">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_10">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc845594_11">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an automatically effective registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> that we filed
with the Securities and Exchange Commission (the &#147;SEC&#148;) as a &#147;well-known seasoned issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), using a &#147;shelf&#148;
registration process. Under this shelf registration process, the Selling Stockholders may from time to time sell Shares described in this prospectus in one or more offerings or otherwise as described under &#147;Plan of Distribution.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the Selling Stockholders have authorized anyone to provide you with any information other than that contained in, or
incorporated by reference into, this prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of our common
stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should not assume that the information contained in or incorporated by reference in this prospectus is accurate as of any date other than their
respective dates. Our business, financial condition, results of operations and prospects may have changed since those dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
prospectus may be supplemented from time to time by one or more prospectus supplements. Such prospectus supplement may add to, update or change the information contained in this prospectus. If there is any inconsistency between the information in
this prospectus and the applicable prospectus supplement, you must rely on the information in the prospectus supplement. You should read both this prospectus and any applicable prospectus supplement together with additional information described
below under the heading &#147;Where You Can Find Additional Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Throughout this prospectus, when we refer to the Selling
Stockholders, we are referring to the Selling Stockholders identified in this prospectus and, as applicable, their permitted transferees or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT>
that may be identified in a supplement to this prospectus or, if required, a post-effective amendment to the registration statement of which this prospectus is a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as
exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the section titled &#147;Where You Can Find Additional Information.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context indicates otherwise, as used in this prospectus, the terms &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148;
&#147;our,&#148; and &#147;Summit,&#148; and similar designations, except where context requires otherwise, refer collectively to Summit Therapeutics Inc. and its consolidated subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_2"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus supplement
contain &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act. These forward-looking statements speak only as of the date of this prospectus or the documents
incorporated by reference in this prospectus, as applicable, and are subject to a number of risks, uncertainties and assumptions described under the sections in this prospectus and the documents incorporated by reference herein entitled &#147;Risk
Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and elsewhere in this prospectus and the documents incorporated by reference herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In some cases, you can identify forward-looking statements by terminology such as &#147;anticipate,&#148; &#147;believe,&#148;
&#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;forecast,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;predict,&#148;
&#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; or the negative of such terms or other similar expressions. These forward-looking statements are based on our management&#146;s current expectations,
assumptions, hopes, beliefs, intentions and strategies regarding future events and are based on currently available information as to the outcome and timing of future events. Although we believe such expectations and assumptions to be reasonable,
they are inherently uncertain and involve a number of risks and uncertainties that are beyond our control. In addition, management&#146;s assumptions about future events may prove to be inaccurate. All readers are cautioned that these
forward-looking statements are not guarantees of future performance and we cannot assure any reader that such statements will be realized or that the forward-looking events and circumstances will occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements in this prospectus and the documents incorporated by reference herein include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop a successful product candidate under the Collaboration and License Agreement, as amended
(the &#147;License Agreement&#148;), with Akeso, Inc. and its affiliates (&#147;Akeso&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to raise sufficient additional funds to make payments under the License Agreement, and fund ongoing
operations and capital needs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of and the ability to effectively execute clinical development of ivonescimab; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing, costs, conduct and outcomes of clinical trials for any product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans with respect to possible future collaborations and partnering arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefits of possible future acquisitions or investments in other businesses, products or
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to pursue research and development of other future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding the potential market opportunity and patient population for commercializing our product
candidates, if approved for commercial use; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our sales, marketing and distribution capabilities and strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish and maintain arrangements with third parties, such as contract research organizations,
contract manufacturing organizations, suppliers, and distributors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and protecting our
intellectual property rights and defending against any intellectual property-related claims; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding expenses, future revenues, capital requirements and needs for additional financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of government laws and regulations in the United States and in foreign countries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and likelihood of regulatory filings and approvals for our product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether regulatory authorities determine that additional trials or data are necessary in order to accept a new
drug application for review and/or approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitive position; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our use of our existing cash, cash equivalents and marketable securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain key scientific or management personnel; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of public health epidemics, the response to such epidemics and the potential effects of such epidemics
on our clinical trials, business, financial results, supply chain and market. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and
circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk
factors and uncertainties may emerge from time to time, and it is not possible for our management to predict all risk factors and uncertainties. Except as required by applicable law, we undertake no obligation to publicly update or revise any
forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. You should, however, review the factors and risks we describe in the reports we will file from time to time
with the SEC after the date of this prospectus. See the section entitled &#147;Where You Can Find Additional Information&#148; in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_3"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus, and
does not contain all of the information that you need to consider in making your investment decision. You should carefully read the entire prospectus, including the risks of investing in our securities discussed under the heading &#147;Risk
Factors&#148; contained in this prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus. You should also carefully read the information incorporated by reference into this prospectus,
including our consolidated financial statements, and the exhibits to the registration statement of which this prospectus is a part. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company
Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-,
caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The Company&#146;s pipeline of product candidates is designed with the goal to
become the patient-friendly, <FONT STYLE="white-space:nowrap">new-era</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">standard-of-care</FONT></FONT> medicines, in the therapeutic area of oncology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current lead development candidate is ivonescimab, a novel, potential
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> bispecific antibody intending to combine the effects of immunotherapy via a blockade of <FONT STYLE="white-space:nowrap">PD-1</FONT> with the
anti-angiogenesis effects of an anti-VEGF compound into a single molecule. On December&nbsp;5, 2022, we entered into a Collaboration and License Agreement (the &#147;License Agreement&#148;) with Akeso, Inc. and its affiliates (&#147;Akeso&#148;)
pursuant to which we have <FONT STYLE="white-space:nowrap">in-licensed</FONT> ivonescimab. Through the License Agreement, we obtained the rights to develop and commercialize ivonescimab in the United States, Canada, Europe, and Japan . The License
Agreement and transaction closed in January 2023 following customary waiting periods. On June&nbsp;3, 2024, we entered into an amendment to the License Agreement with Akeso to expand our territories covered under the License Agreement to also
include the Latin America, Middle East and Africa regions (collectively, and as expanded, the &#147;Licensed Territory&#148;). Our operations are focused on the development of ivonescimab and other future activities, as we determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have begun our development for ivonescimab in <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer (&#147;NSCLC&#148;),
specifically launching Phase III clinical trials in the following indications: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor
(&#147;EGFR&#148;)-mutated, locally advanced or metastatic <FONT STYLE="white-space:nowrap">non-squamous</FONT> NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (&#147;TKI&#148;) (&#147;HARMONi&#148;);
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients <FONT
STYLE="white-space:nowrap">(&#147;HARMONi-3&#148;).</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus, both studies are
enrolling and treating patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The entry into the License Agreement with Akeso represented a significant change in our strategy and our
future operations will be focused on the development of ivonescimab and other future activities as we determine. Our portfolio also includes ridinilazole, a product candidate for treating patients suffering from Clostridioides difficile infection,
also known as C. difficile infection (&#147;CDI&#148;), and <FONT STYLE="white-space:nowrap">SMT-738,</FONT> the first of a novel class of precision antibiotics for combating multidrug resistant infections, specifically carbapenem-resistant
Enterobacteriaceae (&#147;CRE&#148;) infections. All prior development activities related to ridinilazole and <FONT STYLE="white-space:nowrap">SMT-738</FONT> have been terminated; we will continue to pursue partnerships for both assets. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Akeso Collaboration and License Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the License Agreement with Akeso, we received the rights to develop and commercialize ivonescimab in the United States, Canada,
Europe, and Japan. Akeso will retain development and commercialization rights for the rest of the world excluding such licensed territories. In exchange for these rights, we made an upfront payment during the first quarter of 2023 comprised of
$474.9&nbsp;million cash and the issuance of 10&nbsp;million shares of our common stock in lieu of $25.1&nbsp;million cash pursuant to a share transfer agreement. Furthermore, on June&nbsp;3, 2024, we entered into an amendment to the License
Agreement with Akeso to expand our territories covered under the License Agreement to also include the Latin America, Middle East and Africa regions (collectively, and as expanded, the &#147;Licensed Territory&#148;), for which we will pay an
upfront payment of $15.0&nbsp;million cash. In addition, we will potentially owe Akeso (a)&nbsp;milestone payments tied to achievement of regulatory approval of ivonescimab with various regulatory authorities in the Licensed Territory
(b)&nbsp;milestone payments tied to achievement of annual revenue from ivonescimab in the Licensed Territory and (c)&nbsp;royalty payments equal to <FONT STYLE="white-space:nowrap">low-double-digit</FONT> percentage of annual revenues from
ivonescimab in the Licensed Territory. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the License Agreement, we will have final decision-making authority with
respect to clinical development strategy and execution in the Licensed Territory. For <FONT STYLE="white-space:nowrap">co-joined</FONT> studies in which both we and Akeso participate, mutual agreement is required for material decisions; we retain
the exclusive decision making with respect to participating in, and continuing its participation in, <FONT STYLE="white-space:nowrap">co-joined</FONT> studies. In connection with the License Agreement, we agreed to enter into a Supply Agreement with
Akeso (the &#147;Supply Agreement&#148;). Pursuant to the Supply Agreement, Summit agreed to purchase a certain portion of drug substance for clinical and commercial supply. Pursuant to the terms of the License Agreement, we will have final
decision-making authority with respect to commercial strategy, pricing and reimbursement and other commercialization matters in the Licensed Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not assumed any liabilities (including contingent liabilities), nor acquired any physical assets or trade names, or hired or acquired
any employees from Akeso in connection with the License Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Ivonescimab </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ivonescimab is a novel potential <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> <FONT
STYLE="white-space:nowrap">PD-1</FONT> / VEGF bispecific antibody, believed to be the most advanced in clinical development in the Licensed Territory; there are no known <FONT STYLE="white-space:nowrap">PD-1</FONT> / VEGF bispecific antibodies
approved in our Licensed Territory. Engineered with Akeso&#146;s unique Tetrabody technology, ivonescimab, as a single molecule, blocks programmed cell death protein 1 <FONT STYLE="white-space:nowrap">(&#147;PD-1&#148;)</FONT> from binding to <FONT
STYLE="white-space:nowrap">PD-L1</FONT> and <FONT STYLE="white-space:nowrap">PD-L2,</FONT> and blocks vascular endothelial growth factor (&#147;VEGF&#148;) from binding to VEGF receptors. Ivonescimab is designed to potentially allow cooperative
binding of the intended targets, such that the binding of <FONT STYLE="white-space:nowrap">PD-1</FONT> increases the binding affinity of VEGF and the binding of VEGF increases the affinity towards <FONT STYLE="white-space:nowrap">PD-1.</FONT> In
view of the <FONT STYLE="white-space:nowrap">co-expression</FONT> of VEGF and <FONT STYLE="white-space:nowrap">PD-1</FONT> in the tumor micro-environment (&#147;TME&#148;), ivonescimab may block these
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
two pathways more effectively and enhance the antitumor activity, as compared to combination therapy through what is believed to be a differentiated cooperative binding mechanism. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g845594g79r23.jpg" ALT="LOGO" STYLE="width:3.54051in;height:2.67872in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This could differentiate ivonescimab as there is potentially higher expression (presence) of both <FONT
STYLE="white-space:nowrap">PD-1</FONT> and VEGF in tumor tissue and the TME as compared to normal tissue in the body. As shown in Akeso&#146;s <FONT STYLE="white-space:nowrap">in-vitro</FONT> studies, ivonescimab&#146;s tetravalent structure (four
binding sites) enables higher avidity (accumulated strength of multiple binding interactions) in the tumor microenvironment with over 18 fold increased binding affinity to <FONT STYLE="white-space:nowrap">PD-1</FONT> in the presence of VEGF in
vitro, and over 4 times increased binding affinity to VEGF in the presence of <FONT STYLE="white-space:nowrap">PD-1</FONT> in vitro. This tetravalent structure, the intentional novel design of the molecule, and bringing these two targets into a
single bispecific antibody with cooperative binding qualities have the potential to direct ivonescimab to the tumor tissue versus healthy tissue. The intent of this design, together with a half-life of six to seven days, is to improve upon
previously established efficacy thresholds, in addition to side effects and safety profiles associated with these targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to
the two Phase III clinical trials sponsored by us, ivonescimab is also being developed in China and Australia by Akeso in multiple solid tumors and has been dosed in more than 1,800 patients globally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on data published by Akeso at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO 2024) in the HARMONi-A study,
in a single-region (China), randomized, double-blinded Phase III study in patients with NSCLC who have progressed following an <FONT STYLE="white-space:nowrap">EGFR-TKI,</FONT> ivonescimab achieved its primary endpoint of Progression-free Survival
(PFS) when combined with doublet chemotherapy (pemetrexed and carboplatin). Patients experienced a 54% reduction in disease progression or death as compared to placebo plus doublet-chemotherapy (HR: 0.46, 95% CI: 0.34 - 0.62; p&lt;0.001). In a <FONT
STYLE="white-space:nowrap">pre-specified</FONT> subgroup analysis of patients who received a previous third-generation TKI, a hazard ratio of 0.48 was observed. A median Overall Survival (mOS) in this study of 17.1 months was observed, reflecting a
20% reduction in death as compared to placebo plus chemotherapy in the study (HR: 0.80, 95% CI: 0.59 - 1.08). The Phase III study was considered to have demonstrated a tolerable safety profile and a low discontinuation rate for adverse events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on data published by Akeso at the 2024 European Lung Cancer Conference, in the <FONT STYLE="white-space:nowrap">AK112-201</FONT> (Cohort
1), a Phase II study conducted in China, for first-line advanced or metastatic NSCLC patients with squamous histology, (n=63), ivonescimab, combined with carboplatin and paclitaxel, in demonstrated a median PFS of 11.1 months. Median overall
survival was not reached after a median <FONT STYLE="white-space:nowrap">follow-up</FONT> period of 22.1 months. This Phase II study was considered to have demonstrated a tolerable safety profile and a low discontinuation rate for adverse events.
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Akeso announced that ivonescimab administered as a monotherapy resulted in a
statistically significant improvement in PFS when compared to monotherapy pembrolizumab in patients with previously untreated advanced or metastatic NSCLC whose tumors had positive <FONT STYLE="white-space:nowrap">PD-L1</FONT> expression. These
results were generated from the <FONT STYLE="white-space:nowrap">HARMONi-2</FONT> study, also referred to as <FONT STYLE="white-space:nowrap">AK112-303,</FONT> a randomized, single-region (China) Phase III study. Akeso has announced that it intends
to release the results from this study at an upcoming medical conference later in the year. This study was sponsored by Akeso. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to
conduct our current clinical trials, as well as design and conduct additional clinical trial activities for ivonescimab within our Licensed Territory, to support and submit relevant regulatory filings. We also plan to support additional study
activities through its investigator initiated study program. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product Pipeline </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Summit sponsored ivonescimab trials:</B> Ivonescimab is currently being investigated in global Phase III clinical trials. Phase I and II
trials were completed by our partner Akeso. This pipeline reflects clinical trials that have been initiated by us in our Licensed Territory. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g845594g10r40.jpg" ALT="LOGO" STYLE="width:6.26049in;height:0.972203in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">HARMONi study is a multi-regional, potentially registration-enabling clinical trial that we joined with
Akeso, and for which we started initiating and activating sites in North America and Europe during 2023. The first patient in our Licensed Territory was enrolled during the second quarter of 2023. We expect to complete enrollment during the second
half of 2024. The <FONT STYLE="white-space:nowrap">co-primary</FONT> endpoints for this study are progression free survival (&#147;PFS&#148;) and overall survival (&#147;OS&#148;), and the study compares ivonescimab plus doublet-platinum
chemotherapy versus placebo plus platinum-based doublet chemotherapy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">HARMONi-3</FONT> study is a Phase
III, multi-regional, registration-enabling clinical trial for which we initiated activating sites in North Americas and China during fourth quarter of 2023. We plan to initiate additional sites in North America, China, Europe, Japan, and several
other countries through early 2025. Our plan to initiate in new countries and sites is dependent upon the timing and requirements for getting the regulatory approval of the clinical trial applications with the respective regulatory authorities and
approvals from central or local independent review boards. We may decide to modify our plans to go in certain regions or countries based on the timelines and requirements from the respective regulatory regions. We commenced patient enrollment in the
<FONT STYLE="white-space:nowrap">HARMONi-3</FONT> study during fourth quarter of 2023. The primary endpoint for this study is OS, and the study compares ivonescimab plus platinum-based doublet chemotherapy versus pembrolizumab plus platinum-based
doublet chemotherapy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the fourth quarter of 2023, we began collaborating with multiple institutions globally and opened our
investigator-initiated study program across several disease areas. In July 2024, we entered into a collaboration agreement with The University of Texas M.D. Anderson Cancer Center with the intent to further accelerate the development of ivonescimab
through <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our partners at Akeso are sponsoring
multiple, ongoing Phase II and III clinical trials in NSCLC and other cancers outside of our Licensed Territory. We plan to review the data generated from these clinical trials as a part of our consideration for advancing our clinical development
pipeline for ivonescimab in our Licensed Territory. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;3, 2024, we executed the Purchase Agreement with 667, L.P. and Baker Brothers Life Sciences, L.P., affiliates of Baker Bros.
Advisors, L.P. (the &#147;Investors&#148;), pursuant to which the Investors agreed to purchase from us an aggregate of 22,222,222 shares of our common stock, for an aggregate purchase price of approximately $200.0&nbsp;million, at a price per share
equal to $9.00 (the &#147;Private Placement&#148;). The Private Placement closed on June&nbsp;6, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offer and sale of shares of
common stock issued to the Investors were not initially registered under the Securities Act or any state securities laws. We relied on the exemption from the registration requirements afforded by Section&nbsp;4(a)(2) of the Securities Act and/or
Regulation D promulgated thereunder for the Private Placement. In connection with their execution of the Purchase Agreement, each of the Investors represented to us that such Investor is either (i)&nbsp;an &#147;accredited investor&#148; as defined
in Regulation D of the Securities Act, or (ii)&nbsp;a qualified institutional buyer (as defined in Rule 144A of the Securities Act), and that the securities purchased by such Investor were being acquired solely for its own account and for investment
purposes and not with a present view to its future public sale or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;3, 2024, in connection with the Purchase
Agreement, the Company entered into a Registration Rights Agreement with the Investors (the &#147;Registration Rights Agreement&#148;). Pursuant to the Registration Rights Agreement, we agreed to prepare and file as soon as reasonably practicable, a
registration statement with the SEC to register for resale the shares of our common stock issued under the Purchase Agreement, and to cause the registration statement to become effective within 75 days after the filing of the registration statement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Summit
Therapeutics Inc. was incorporated in Delaware on July&nbsp;17, 2020. Our principal executive office is located at 601 Brickell Key Drive, Suite 1000, Miami, FL 33131 and our phone number is (305) <FONT STYLE="white-space:nowrap">203-2034.</FONT>
Our website is https://www.smmttx.com. Information contained on or accessible through our website is not incorporated by reference into this prospectus and should not be considered a part of this prospectus. We have included our website in this
prospectus solely as an inactive textual reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains references to our trademarks and to trademarks belonging to
other entities. Solely for convenience, trademarks and trade names referred to in this prospectus, including logos, artwork and other visual displays, may appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> or <SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not
intend our use or display of other companies&#146; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common stock offered by the Selling Stockholders</B> </P></TD>
<TD>22,222,222 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Use of Proceeds</B> </P></TD>
<TD>We will not receive any proceeds from the sale of the Shares covered by this prospectus. See &#147;Use of Proceeds.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Risk Factors</B> </P></TD>
<TD>An investment in our common stock involves a high degree of risk. See &#147;Risk Factors&#148; on page 7 of this prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus for a
discussion of the factors you should consider before deciding to invest in shares of our common stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Global Market symbol</B> </P></TD>
<TD>SMMT </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our common stock involves a high degree of risk. Before deciding whether to invest in our common stock, you should consider
carefully the risks and uncertainties described under the heading &#147;Risk Factors&#148; contained in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as updated and supplemented by subsequent Quarterly Reports
on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that we have filed with the SEC, and by our other filings we make with the SEC which are incorporated by reference into this
prospectus, together with other information in this prospectus and the documents incorporated by reference into this prospectus. The risks described in these documents are not the only ones we face, but those that we consider to be material.
Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. Our business, financial condition, or results of operations could be materially adversely affected by the materialization of any
of these risks. The trading price of our common stock could decline due to the materialization of any of these risks and you may lose all or part of your investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about our SEC filings, please see &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain
Information by Reference.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the resale of the Shares by the Selling Stockholders. We will not receive any proceeds from the sale or other disposition
of the Shares offered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders will bear all fees, commissions and discounts, if any, attributable to
the sale of the Shares. We will bear all other costs, expenses and fees in connection with the registration of the Shares to be sold by the Selling Stockholders pursuant to this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_6"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have prepared this prospectus to allow the Selling Stockholders to offer and sell from time to time up to 22,222,222 Shares. We are
registering the offer and sale of the Shares to satisfy certain registration obligations that we granted the Selling Stockholders in the Private Placement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth (i)&nbsp;the name of each Selling Stockholder; (ii)&nbsp;the number of shares of common stock beneficially
owned by each Selling Stockholder; (iii)&nbsp;the number of Shares that may be offered under this prospectus; and (iv)&nbsp;the number of shares of common stock beneficially owned by each Selling Stockholder assuming all of the Shares covered hereby
are sold. We do not know how long the Selling Stockholders will hold the Shares before selling them. We currently have no agreements, arrangements or understandings with the Selling Stockholders regarding the sale or other disposition of any Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to our
common stock. Generally, a person &#147;beneficially owns&#148; shares of common stock if the person has or shares with others the right to vote those shares or to dispose of them, or if the person has the right to acquire voting or disposition
rights within 60 days. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth in the table below is based upon information obtained from the Selling Stockholders. The
percentage of shares beneficially owned prior to, and after, the offering is based on 724,320,201 shares of our common stock outstanding as of June&nbsp;30, 2024 and assumes the Selling Stockholders dispose of all of the Shares covered by this
prospectus and do not acquire beneficial ownership of any additional shares of common stock. The registration of the Shares does not necessarily mean that the Selling Stockholders will sell all or any portion of the Shares covered by this
prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this prospectus, the term &#147;Selling Stockholders&#148; includes the Selling Stockholders listed in the table
below, together with any additional Selling Stockholders listed in a prospectus supplement, and their donees, pledgees, assignees, transferees, distributees and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> that receive Shares in any <FONT STYLE="white-space:nowrap">non-sale</FONT> transfer after the date of this prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common Stock<BR>beneficially owned before<BR>this offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common&nbsp;Stock<BR>offered&nbsp;pursuant<BR>to&nbsp;this&nbsp;prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common Stock<BR>beneficially owned<BR>after this offering&nbsp;<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Selling Stockholder</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of<BR>outstanding<BR>shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares <SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of&nbsp;shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Baker Bros. Advisors LP <SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,222,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,222,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than one percent (1%) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents all of the Shares that each Selling Stockholder may offer and sell from time to time under this
prospectus. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes each Selling Stockholder sells the maximum number of Shares possible in this offering.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 1,874,633 shares of common stock held directly by 667, L.P. (&#147;667&#148;) and (ii)
20,347,589 shares of common stock held directly by Baker Brothers Life Sciences, L.P. (&#147;Life Sciences&#148;, and together with 667, the &#147;BBA Funds&#148;). Baker Bros. Advisors LP (&#147;BBA&#148;) is the investment adviser to the BBA Funds
and has the sole voting and investment power with respect to the securities held by the BBA Funds and thus may be deemed to beneficially own such securities. Baker Bros. Advisors (GP) LLC (&#147;BBA GP&#148;) is the sole general partner of BBA and
thus may be deemed to beneficially own the securities held by the BBA Funds. The managing members of BBA GP are Julian C. Baker and Felix J. Baker, who may be deemed to beneficially own the securities held by the BBA Funds. Felix J. Baker, BBA and
BBA GP disclaim beneficial ownership of all shares held by the BBA Funds, except to the extent of their indirect pecuniary interest therein. The business address of BBA, BBA GP, Julian C. Baker and Felix J. Baker is 860 Washington Street, 3rd Floor,
New York, NY 10014. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_7"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the resale of the shares of our common stock held by the Selling Stockholders from time to time after the date of this
prospectus. We will not receive any of the proceeds from the sale by the Selling Stockholders of the shares of our common stock. The Selling Stockholders will bear all fees, commissions and discounts, if any, attributable to the sales of shares and
any transfer taxes. We will bear all other costs, expenses and fees in connection with the registration of shares of our common stock to be sold by the Selling stockholders pursuant to this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#147;Selling Stockholders&#148; includes donees, pledgees, transferees or other successors in interest selling securities received
after the date of this prospectus from the Selling Stockholders as a gift, pledge, partnership distribution or other transfer. The Selling Stockholders will act independently of us in making decisions with respect to the timing, manner and size of
each sale. Such sales may be made on the principal trading market for our common stock or any other stock exchange, market or trading facility on which our common stock is traded or in private transactions. These sales may be at fixed or negotiated
prices. The Selling Stockholders may use any one or more of the following methods when selling securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker dealer will attempt to sell the common stock as agent but may position and
resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker dealer as principal and resale by the broker dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">distribution to employees, members, limited partners or stockholders of the Selling Stockholders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions through broker dealers that agree with the Selling Stockholders to sell a specified number of
such common stock at a stipulated price per security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by pledge to secured debts and other obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delayed delivery arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters, broker-dealers or agents; provided that in no event shall any resales by the Selling
Stockholders take the form of an underwritten offering (as the term &#147;underwritten public offering&#148; is commonly understood, which for clarity does not include a transaction that does not involve the purchase by such broker-dealer of
securities with a view to public resale thereby, but which transaction may be treated similarly to an underwritten public offering in terms of the procedures to be followed thereby as a matter of law or customary practice) without our prior consent;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in &#147;at the market&#148; offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at
prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings
through sales agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in options transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may also sell the shares of our common stock under Rule 144 or any
other exemption from registration under the Securities Act, if available, rather than under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, each Selling
Stockholders that is an entity may elect to make a pro rata <FONT STYLE="white-space:nowrap">in-kind</FONT> distribution of securities to its members, partners or stockholders pursuant to the registration statement of which this prospectus is a part
by delivering a prospectus with a plan of distribution. Such members, partners or stockholders would thereby receive freely tradeable securities pursuant to the distribution through a registration statement. To the extent a distributee is our
affiliate (or to the extent otherwise required by law), we may, at our option, file a prospectus supplement in order to permit the distributees to use the prospectus to resell the securities acquired in the distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the selling stockholder (or, if any broker-dealer acts as agent for the purchaser of our common stock, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the
case of an agency transaction not in excess of a customary brokerage commission in compliance with Financial Industry Regulatory Authority, or FINRA, Rule 5110; and in the case of a principal transaction a markup or markdown in compliance with FINRA
Rule 2121. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of
distribution. In connection with the sale of our common stock or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of our
common stock in the course of hedging the positions they assume. The Selling Stockholders may also sell our common stock short and deliver these shares to close out their short positions, or loan or pledge the securities to broker-dealers that in
turn may sell these shares. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or
other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The Selling
Stockholders may also pledge securities to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged securities pursuant to this prospectus (as
supplemented or amended to reflect such transaction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In effecting sales, broker-dealers or agents engaged by the Selling Stockholders
may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the Selling Stockholders in amounts to be negotiated immediately prior to the sale. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders have informed us that they do not have any written or oral agreement or understanding, directly or indirectly, with
any person to distribute the shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay certain fees and expenses incurred by us incident to the
registration of the resale of the Shares. We have agreed to indemnify the selling stockholder against certain losses, claims, damages and liabilities, including liabilities under the Securities Act, and the Selling Stockholders may be entitled to
contribution. We may be indemnified by the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the Selling
Stockholders specifically for use in this prospectus, or we may be entitled to contribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The resale securities will be sold only
through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the
applicable state or an exemption from the registration or qualification requirement is available and is complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under applicable
rules and regulations under the Exchange Act, any person engaged in the distribution of the resale shares of our common stock may not simultaneously engage in market making activities with respect </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to our common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to
applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of our common stock by the Selling Stockholders or any other person. We will make copies of
this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the time a particular offer of securities is made, if required, a prospectus supplement will be distributed that will set forth the
number of securities being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission and other item constituting compensation, any discount,
commission or concession allowed or reallowed or paid to any dealer, and the proposed selling price to the public. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed with
the Selling Stockholders to keep the registration statement of which this prospectus forms a part effective until the earlier of (i)&nbsp;the date on which the Selling Stockholders cease to hold any Shares issued pursuant to Purchase Agreement, and
(iii)&nbsp;all the Shares held by the Selling Stockholders may be sold without registration under Rule 144 and without being subject to any volume, manner of sale or publicly available information requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_8"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Baker&nbsp;&amp; Hostetler LLP, Los Angeles, California, will pass upon the validity of the shares of our common stock offered by this
prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_9"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements incorporated in this prospectus by reference to the Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 have been so incorporated in reliance on the report (which contains an explanatory paragraph relating to the Company&#146;s ability to continue as a going concern
as described in Note 3 to the consolidated financial statements) of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_10"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and other reports, proxy statements and other information with the SEC. Our SEC filings are available to the public
over the Internet at the SEC&#146;s website at www.sec.gov. Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and Current Reports on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> including any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act can also be accessed free of charge through
the Internet. These filings will be available as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the SEC. This prospectus omits some information contained in the
registration statement in accordance with SEC rules and regulations. You should review the information and exhibits in the registration statement for further information about us and our subsidiaries and the securities we are offering. Statements in
this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete
document to evaluate these statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc845594_11"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to incorporate by reference the information and reports we file with it, which means that we can disclose important
information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus, and information that we file after the date hereof with the SEC will automatically update and supersede the
information already incorporated by reference. We are incorporating by reference the documents listed below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000031/smmt-20231231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended December&nbsp;31, 2023, as filed on February&nbsp;20, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31,
2024, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000085/smmt-20240331.htm">May<U></U>&nbsp;1, 2024</A> and for the quarter ended June&nbsp;
30, 2024, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000117/smmt-20240630.htm">August&nbsp;6, 2024</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000004/smmt-20240103.htm">January
<U></U>&nbsp;3, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000023/smmt-20240207.htm">February<U></U>&nbsp;
8, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000036/smmt-20240305.htm">March<U></U>&nbsp;
5, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000043/smmt-20240322.htm">March<U></U>&nbsp;
22, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000051/smmt-20240402.htm">April<U></U>&nbsp;
3, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000064/smmt-20240411.htm">April<U></U>&nbsp;
11, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1599298/000159929824000089/smmt-20240513.htm">May<U></U>&nbsp;
13, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000092/smmt-20240524.htm">May<U></U>&nbsp;
24, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000159929824000096/smmt-20240530.htm">May<U></U>&nbsp;
30, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000119312524152292/d38200d8k.htm">June<U></U>&nbsp;3,&nbsp;
2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001599298/000119312524152309/d768276d8k.htm">June<U></U>&nbsp;
3, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1599298/000119312524162715/d786440d8k.htm">June<U></U>&nbsp;
17, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1599298/000159929824000103/smmt-20240627.htm">June<U></U>&nbsp;27, 2024</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our Common Stock contained on our Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> dated <A HREF="http://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627d8k12b.htm">September<U></U>&nbsp;18, 2020</A>, including any amendment or report filed for the purpose of updating
such description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act
shall be deemed incorporated by reference in this prospectus and to be a part of this prospectus from the date of filing of those documents, with the exception of any portion of any report or document that is not deemed &#147;filed&#148; under such
provisions on or after the date of this prospectus, until the earlier of the date on which: (1)&nbsp;all of the securities, the offer and resale of which are registered hereunder, have been sold; or (2)&nbsp;the registration statement of which this
prospectus is a part has been withdrawn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under no circumstances will any information filed under current items 2.02 or 7.01 of Form <FONT
STYLE="white-space:nowrap">8-K</FONT> be deemed incorporated herein by reference unless such Form <FONT STYLE="white-space:nowrap">8-K</FONT> expressly provides to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon written or oral request, we will provide without charge to each person to whom a copy of the prospectus is delivered a copy of the
documents incorporated by reference herein (other than exhibits to such documents unless such exhibits are specifically incorporated by reference herein). You may request a copy of these filings, at no cost, by writing, calling or emailing us at the
contact information set forth below. We have authorized no one to provide you with any information that differs from that contained in this prospectus. Accordingly, we take no responsibility for any other information that others may give you. You
should not assume that the information in this prospectus is accurate as of any date other than the date of the front cover of this prospectus </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Summit Therapeutics Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">601
Brickell Key Drive, Suite 1000 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Miami, FL 33131 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(305) <FONT STYLE="white-space:nowrap">203-2034</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN THE PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;14. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth an estimate of the fees and expenses payable by us in connection with the issuance and distribution of the
securities being registered (other than the underwriting discounts and commissions and expenses incurred by the Selling Stockholders in disposing of its Shares). All the amounts shown are estimates, except for the SEC registration fee. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;15. Indemnification of Directors and Officers. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to or is threatened to
be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses
(including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if he or she acted in good faith and in a manner he or she
reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor because the person is or was a director, officer, employee or agent of the corporation, or is or was serving
at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees) actually and reasonably incurred by the
person in connection with the defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, except that no
indemnification shall be made with respect to any claim, issue or matter as to which he or she shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines
that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who
is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise,
against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify the person against such liability
under Section&nbsp;145 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrant&#146;s Certificate of Incorporation provides that the registrant will indemnify each
person who was or is a party or threatened to be made a party to or is involved in any threatened, pending or completed action, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the registrant) by reason of the fact that he or she is or was a director
or officer of the registrant, or is or was serving at the registrant&#146;s request as a director or officer of another corporation, partnership, joint venture, trust or other enterprise to the fullest extent permitted by the DGCL. The
registrant&#146;s Certificate of Incorporation provides that any reasonable, documented, <FONT STYLE="white-space:nowrap">out-pocket</FONT> expenses must be advanced to these indemnitees under certain circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indemnification provisions contained in the registrant&#146;s Certificate of Incorporation are not exclusive. In addition, the registrant
has entered into indemnification agreements with each of its directors and executive officers. Each indemnification agreement provides that the registrant will indemnify the director or executive officer to the fullest extent permitted by law for
claims arising in his or her capacity as a director or executive officer, provided that he or she acted in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, the registrant&#146;s best interests and, with
respect to any criminal proceeding, had no reasonable cause to believe that his or her conduct was unlawful. In the event that the registrant does not assume the defense of a claim against a director or executive officer, the registrant is required
to advance his or her expenses in connection with his defense, provided that he or she undertakes to repay all amounts advanced if it is ultimately determined that he or she is not entitled to be indemnified by the registrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the registrant maintains standard policies of insurance under which coverage is provided to the registrant&#146;s directors and
officers against losses arising from claims made by reason of breach of duty or other wrongful act, and to the registrant with respect to payments which may be made by the registrant to such directors and officers pursuant to the above
indemnification provisions or otherwise as a matter of law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;16. Exhibits. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex31.htm">Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant&#146;s Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;001-36866),</FONT> filed with the Securities and Exchange Commission on September<U></U>&nbsp;18, 2020) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1599298/000159929822000086/summittherapeuticsinc-de.htm">Amendment to Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant&#146;s
 Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;001-36866),</FONT> filed with the Securities and Exchange Commission on July<U></U>&nbsp;29, 2022) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1599298/000159929823000012/exhibit51summittherapeut.htm">Amendment No.<U></U>&nbsp;
2 to Restated Certificate of Incorporation (incorporated by reference to Exhibit 5.1 to Registrant&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;
001-36866),</FONT> filed with the Securities and Exchange Commission on January<U></U>&nbsp;20, 2023)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1599298/000119312520248702/d76627dex32.htm">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Registrant&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;001-36866),</FONT> filed with the Securities and Exchange Commission on September<U></U>&nbsp;18, 2020)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d845594dex51.htm">Opinion of Baker&nbsp;&amp; Hostetler LLP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d845594dex231.htm">Consent of PricewaterhouseCoopers LLP, an independent registered public accounting firm for the Registrant </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d845594dex51.htm">Consent of Baker&nbsp;&amp; Hostetler LLP (included in Exhibit 5.1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Powers of Attorney (included on signature page hereto) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>107*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d845594dexfilingfees.htm">Filing Fee Table </A></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;17. Undertakings. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC
pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective
registration statement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>provided, however, </I>that
paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to
Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration
statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date
the filed prospectus was deemed part of and included in the registration statement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Each prospectus required to be filed
pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x)&nbsp;for the purpose of providing the information required by
Section&nbsp;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of
sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that
no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or
made in any such document immediately prior to such effective date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act of 1933, each filing of the registrant&#146;s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#146;s annual report
pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of
expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida,
on August&nbsp;6, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SUMMIT THERAPEUTICS INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert W. Duggan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Robert W. Duggan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:&nbsp;Chief&nbsp;Executive Officer and Executive Chairman; Principal Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Dr.&nbsp;Mahkam Zanganeh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Dr.&nbsp;Mahkam Zanganeh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:&nbsp;Chief&nbsp;Executive Officer; President and member of the Board; Principal Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Robert W. Duggan,
Dr.&nbsp;Mahkam Zanganeh and Manmeet Soni, and each of them singly, as the undersigned&#146;s true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of
substitution, for the undersigned in any and all capacities, to sign any or all amendments to this Registration Statement (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents full power and authority to do and perform each and every act and
thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as the undersigned might or could do in person, hereby and about the premises hereby ratifying and confirming all that said <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agent, proxy and agent, or their substitute, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the
capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Title</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Date</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Robert W. Duggan</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Robert W. Duggan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Executive Officer and Executive Chairman</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Principal Executive Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Dr.&nbsp;Mahkam Zanganeh</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dr.&nbsp;Mahkam Zanganeh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Executive Officer, President and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Principal Executive Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Manmeet S. Soni</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Manmeet S. Soni</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Operating Officer, Chief Financial Officer and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Principal Financial and Accounting Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Dr.&nbsp;Robert Booth</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dr.&nbsp;Robert Booth</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Dr.&nbsp;Alessandra Cesano</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dr.&nbsp;Alessandra Cesano</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Kenneth Clark</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kenneth Clark</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Jeff Huber</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Jeff Huber</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Dr.&nbsp;Mostafa Ronaghi</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dr.&nbsp;Mostafa Ronaghi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Dr.&nbsp;Yu Xia</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dr.&nbsp;Yu Xia</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">August&nbsp;6, 2024</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d845594dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g845594dsp029a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g845594dsp029b.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;6, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Summit
Therapeutics Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">601 Brickell Key Drive, Suite 1000 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miami,
FL 33131 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
acted as counsel to Summit Therapeutics Inc., a Delaware corporation (the&nbsp;&#147;<B>Company</B>&#148;), in connection with the filing of the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the
&#147;<B>Registration Statement</B>&#148;) with the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;) under the Securities Act of 1933, as amended (the &#147;<B>Act</B>&#148;), covering the registration for resale of up to an
aggregate of 22,222,222 shares (the &#147;<B>Shares</B>&#148;) of the Company&#146;s common stock, par value $0.01 per share (the &#147;<B>Common Stock</B>&#148;), held by the selling stockholders identified in the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have examined such documents and such matters of fact and law as we deem necessary to render the opinion contained herein. In our
examination, we have assumed, but have not independently verified, the genuineness of all signatures, the conformity to original documents of all documents submitted to us as certified facsimile or other copies, and the authenticity of all such
documents. As to questions of fact material to this opinion, we have relied on certificates or comparable documents of public officials and of officers and representatives of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on such examination, we are of the opinion that the Shares are validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion expressed herein is limited to the General Corporation Law of the State of Delaware and we express no opinion as to the effect on
the matters covered by this letter of the laws of any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this letter as Exhibit 5.1
to the Registration Statement and to the reference to our firm under the heading &#147;Legal Matters&#148; in the prospectus included in the Registration Statement. In giving such consent, we do not hereby admit that we are in the category of
persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Baker&nbsp;&amp; Hostetler LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BAKER&nbsp;&amp; HOSTETLER LLP</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g845594dsp029c.jpg" ALT="LOGO">
 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d845594dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> of Summit Therapeutics
Inc. of our report dated February&nbsp;20, 2024 relating to the financial statements, which appears in Summit Therapeutics Inc.&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023. We
also consent to the reference to us under the heading &#147;Experts&#148; in such Registration Statement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ PricewaterhouseCoopers LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">San Jose, California</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">August&nbsp;6, 2024</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d845594dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Tables </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Summit
Therapeutics Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Table 1: Newly Registered and Carry Forward Securities </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Security<BR>Type</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Security<BR>Class</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Fee<BR>Calculation<BR>or Carry<BR>Forward<BR>Rule</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Amount<BR>Registered (1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;">Proposed<BR>Maximum<BR>Offering<BR>Price Per<BR>Unit (2)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Maximum</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Aggregate</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Offering</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Price</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Fee</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Rate</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">Amount of<BR>Registration<BR>Fee</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-LEFT:1px solid #000000; padding-left:8pt">Fees to Be Paid</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="padding-bottom:1pt ;">Common Stock, par value $0.01 per share</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">Other</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">22,222,222</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$9.68</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$215,111,108.96</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">0.00014760</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">$31,750.40</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">Total Offering Amounts</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">$215,111,108.96</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">$31,750.40</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">Total Fees Previously Paid</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&#151;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;">Total Fee Offsets</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; padding-right:2pt">&#151;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="1" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000">Net Fee Due</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$31,750.40</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">The shares of common stock, par value $0.01 per share (&#147;Common Stock&#148;), of the Registrant will be
offered for resale by the selling stockholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), the shares being registered hereunder include such indeterminate number of shares of Common Stock as
may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of
the Securities Act. The proposed maximum offering price per share and maximum aggregate offering price are calculated using the average of the high ($10.18) and low ($9.18) prices of the Common Stock as reported on the Nasdaq Global Market on
August&nbsp;5, 2024, which date is within five business days prior to the filing of this registration statement. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g845594dsp029a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845594dsp029a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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'\Z"M#A/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g845594dsp029b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845594dsp029b.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MVBVACF<D?+M<L!@^ORF@#)O?&4=KJU]I\&C:E>O8A//>VB5E7<NX=6!/'H*
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MET+<QB-5B\T>5@YW*2".G&,4 =KIFFVVCZ7;:=9H4MK:,1QJ3D@#U/>@"W0
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M.O;^YN(@UQ*8D6=B&9U6%%//^\I]* (=,\,H9[Z74//827\DZ0F<^41NRI*
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M<-C]* +E '/+H^I'Q"VH3O:7$8D_<^8'W0IC&%'0'KSU.: -*?3VFUNROQ(
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M );;2=.L[I[JVM(HIGSEU'J<G'ID]<4 6%@A2YDN%C432*JLXZD#.!^&3^=
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MM;QK 85<,C1OA23C!*L<\_+F@#6\/V-_I-Z\-U%=2V]B!9VSYW^:';<9#ST
MVJ3_ +)H HC3[K[ T4.G7JZP(Y!=7.XH),GD!NC%A]W'W?:@"7^R3=ZG +/3
M[FWT<SQ&2&16C#,%DW':><<H#V)]: +.E:')I][ILT5K)&RWERLK$DXA._RP
M>?N\)@=N* .PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
- H * "@ H * "@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g845594dsp029c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845594dsp029c.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MH,#- #QK6FF S?;8A&&"9)Q\Q&0/Q[>M "R:SIL5O'.][$(I 2K;NH'4_04
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M>1!H5+/EL;0.I_#OZ4 $&J6-R0(;J-R6V  ]3C./RYH 1=7T]Y8HEO(B\OW
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MB*>"431LR[EW#(P1W&": *,VEZG=!)KB\A:>.59(XA&?*& 1@C.23NSG/84
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M]\"LK @DX4'KNR,G@#H?K0 ^WUK4;ZXLXXWAA"W,RSL8SATC&#@;N.2.YZ4
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M8SZ_6@!YTRQ+PN;.'=  (CL'R = /2@"NN@Z:+I[AK6-W.W:&0$1@#@+Z>M
M%PV=LR[3!&1N+X*C[QSD_4Y/YT 0G2=.,RS&Q@,JXP_EC(QT_*@"Y0 4 0W-
MI;WD)AN8$FCSG:Z@B@"NVC:8\,<36%N8XP0BF,84'KB@"=+*UC552WC4*V\
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# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g845594g10r40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845594g10r40.jpg
M_]C_X  02D9)1@ ! 0$ H0"A  #_[1'^4&AO=&]S:&]P(#,N,  X0DE-! 0
M     "4< 5H  QLE1QP"   "   < E  $51U<&EK:6XL($QA;F-E(%,N #A"
M24T$)0      $*2'['VF0Q+BDE7$--&0N6$X0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q 9"^EX         IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ "A?2\
M 0 " *%]+P !  (X0DE-!"8       X             /X   #A"24T$#0
M    !    '@X0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      S4    &              "=   #\P         !
M                          $              _,   "=
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   "=     %)G:'1L
M;VYG   #\P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG    G0    !29VAT;&]N9P   _,    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!$       $! #A"24T$%       !     @X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4
M( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(      4Y-
M30 J    "  ( 1(  P    $  0   1H !0    $   !N 1L !0    $   !V
M 2@  P    $  @   3$  @   !X   !^ 3(  @   !0   "< 3L  @   !(
M  "PAVD !     $   #$    \    *$    !    H0    %!9&]B92!0:&]T
M;W-H;W @0U,V("A7:6YD;W=S*0 R,#(T.C X.C V(# S.C(R.C W %1U<&EK
M:6XL($QA;F-E(%,N      .@ 0 #     ?__  "@ @ $     0   _.@ P $
M     0   )T         !@$#  ,    !  8   $:  4    !   !/@$;  4
M   !   !1@$H  ,    !  (   (!  0    !   !3@("  0    !
M      !(     0   $@    !.$))30/]       (          #_X0%617AI
M9@  34T *@    @ " $2  ,    !  $   $:  4    !    ;@$;  4    !
M    =@$H  ,    !  (   $Q  (    >    ?@$R  (    4    G $[  (
M   2    L(=I  0    !    Q    /    "A     0   *$    !061O8F4@
M4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C R-#HP.#HP-B P,SHR,CHP-P!4
M=7!I:VEN+"!,86YC92!3+@     #H $  P    '__P  H ( !     $   /S
MH , !     $   "=          8! P #     0 &   !&@ %     0   3X!
M&P %     0   48!*  #     0 "   " 0 $     0   4X" @ $     0
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M8G*Q"$2BX7."LL+P)35C)C:#P_$G19.C_\0 &0$! 0$! 0$
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M/X+GQ\O_ *3>?AJ:+4_3$&.%K7S"[=(97!&6Y?03\ X.INK@5"9ALF796<X
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ML>B%HC/%QN_LLT_;4(V*+<4)!V*,O:M2&7!390@/>$2R;9]RB^U-^U+@'+-
M2P4W[U MQ02$;L47VH+#>@9G;L4[UQ-@=JD9;"H']^"G8%%Q9+WS%D4 YJ5'
MM4 VWHB;6V*1L47S4FV>85$*"+G-2T\%+=IN<T^RS@YN5[K>/^'BXD)H_=OD
M?>6DCL.87L4#$]3H(<RGQW,:[: !;?\ FN/-Q9Q:&^.K&;LDZ3<35>7Q;.P(
M,X]D Z.0 ]1JQW!TS$CXRICXT9SXCIECKD?S!>=49^8J4^^9G(A?%?M/L _!
M=<C-1I"=A34N\B-"<'-/@;K'6C%9Y9O=MGIWG(T.JR+(<5S"80R&ST6K+*JY
MT7HREQ$=8EXN=OWW+0^(<15&NQX<:>C%SX8L-G"WX*[%QE68M+%/,T3+M-[&
MW$GAWKA3XLVAUGGO,MX4/#P&$)5TA ;-Q7$$AS]#[IXGP61:B++86B0IJ7;*
MO 'FM>'\."^<:1CRMTJ7$*2G8K&;VZ(M_;N5A_2-B&-#B-C3KRQVZP_)8ZM4
MU-^^+,QZ*!B.!(1)B2@,C2I?9X,1C?O.&P^U9GCZC2$2ART]-RK8,RV9AO-G
MD\3NRW+1]"QG6J%*F!)S1T2;[N)/#O7#$6,:S7Y4RT_-.="TK[!W]W>K/BU7
M9GFA])R^G4L+2[:= 9,.;":W1+@VWFCBL4J$7$]*HD=KJ;!A0@1FV/#/WN%N
M]:8H.,*Q0Y80:?./8T< /R[E=J'2/B&=EG2\>>BO:[:-$?DLSXLTUQ)5SQ53
MBQ:=BNF8T2+$/GO&>2^AN@XZ&%+C8-ONL7SL;Z)N[/;DO>H>,:O1I7J\E,.;
M".ZPX <.Y>SR.+.(APHKPF[:O1$1])J@!Z)B._NY,/F_3!5]$V&F/^@+5-'Q
M55*3.19J6F3K'YG9W]W>NN!BBJ0*S&JC)AW68I!)L.%N"XSXOR[SSWADW3N'
M'&NEE;4@?_\ 2(L!AY 6*N5RKS5;GS-3[]*-HV)XYD_BJ;2+$;/%>KAHQBSS
M53>9DVW0;%%\MJ9<5T0&=\U.Q1<;K)<$[5"#8>]2;J+CCL0$'@@ $WN@S0';
ML06WE!-@;[B@RRNH!&>:<E;B1O3=90#WI<<5% ;J=RC*Z7!WY(B0BB]SDF6\
MH''--V29=UT!&PV0L7W;UR;D"N-PN0.W-:A7=2K^5I3_ (K?^H+[)PC_ .PR
M?_!;_P!(7QM2;FJRENU;_<+[)PG_ .PR5^Q9_P!(7R_.^GL\3^SVAL1!L1?,
M?0<7 7N2OGW_ !&$F8ECQM_^Q?040$C):$_Q!RT:/,2X@PRXBU[?\Z]'C3%-
M=Y>?R+S3:&DH0&BCFA=[:;/-'V+O@N1I\X=L%WP7VXY*9A\S"95@!;>H "L^
M39WLG?!2*;.]B[X)[*=I:=*P&1L"H '>K(IL]?[%WP0TZ='[EWP3V4[+3/Z=
M ' 9J!ORLK!I\Z,M2[X(:=.WR@N^"OMIV8SIT$#@HL#N5CR=.=D[X*13IS.\
M)VSN3V4+C.E8-&>2@-%MF:LBG3H_=.^"DTZ=W0G?!3.G:8S;Z5=$9W" ;<E9
M%-G;']$[X(*=.V^Q=\$SHVMITK "VQ+#@K7DZ=MG!=\$\FSH/V3K>Q/93M,9
MTK6[DL-P5@T^=!RA.^"GR=.C]R[X)[*5QG2L6C@HT=ZM"GSI'V+O@H\G3H_=
M.^"9T[3&=*UM]E-N 5CR=.C9"<>2"G3W8N^"9T[+3I6T1OO=2 ."L&GSH_<N
M^""GSO8N^">RG9C.E<- &]  <[*P:=.]B[X*?)T[V+O@GLI,9TK6!W(!EL5@
M4Z=S_0N^"GR=.[-4[X)G28SI6 '!1DK1IT[:VI=\% IL[?[%WP3V4[+3I6L!
MN0C/8K7DZ=[)WP0TZ=[%WP3V4;,9TK@=Z@M"LBG3O8N^"D4Z='[EWP5]E,_L
MBF=*1%KBV]97&%\*,XV_[5CYITZ3E =M[EDL:7BG#C8&@==LT;?RK/LHB?M)
MIJG],0T<AM4V!V9JUY-G6[8+O@N(ITZ!]B[X)[*=F,Z5@ ,B,U(M;@K/DZ=[
M%WP3R;.G,07?!/93LBF=*U@F2L>39VY_0N^">39XW_0N^">VG:VJTKBU\U+1
MW+O%-G>Q=\%+:=.D_9.')6.6DB)TKY6V*0.Y6/)\[V1^">3IW.\)WP5]E.UQ
MG2O;@"@ ML5@4^='[IWCDH\GSO9.^">RDM.G19+=R[Q3YP?NG?!3Y/G+?8N^
M">RG9:=*UL\DRX!6#39WL7?!#3IWLG?!3VT[28G2N;63*^2[Q3IZ_P!B[X*?
M)T]V+O@GMIV6G2L"$R5D4V=S&I=;V(*;.]B[;W*>VG:6JTK; 3EFF6RRL^39
MT_N7?!0*;/ _9.^">VG9:=*]AP0 =ZM"G3I/V+O@H\G3N?Z%WP5SIVMITK6L
M=BDM!.Q6/)T[V3O@@IT[O@N^"9T[,9TK$#@IMMR5CR=/9_H7?!/)T[O@N^">
MRG9%,Z5@.Y9+@H>?-6]7\0O$%.G=\%WP60X2EH\LZ8,Q#<T.;8<U)Y*3&JWP
MQB9'ZS$7$!79BFSIF8FC <1[%U"G3O8N^"U')3LM5I7+0H%N"L>3IZ]M4ZWL
M4>39Z_V+O@I/+2EITK[MB9< K IL[;[)WP3R=/6^Q=\%/;3M;5:=  '%38;+
M67>*;/#,P7?!/)\Z?W3O@K'+3M8IG2N!GD%-K[@K I\[;*$[AN3R=.C;"=\%
M?928SI6(SV* .X*UY/G#^Y=\%'DZ=[%V7@I[*=EITK6%[60M&Q613IWL7?!1
MY.G=FJ=\$]E.TQG2N67",:6V+201O"M^3YT?N7?!#3YWL76]B9\>TBF?W"Q#
MQ!6H<,0X%5G8<-N0#8S@JT]4ZA4+">FYB8#=@B/+A\4-.G+VU#K>(4"FSN=H
M+AR6,N/;44SISDJK/R+'-DYZ/+M=D6PXA:/AX*M&B1(\1T2*XQ'NVO<;E=WD
MV= S@F_L04V=M;4N^"U[*$M5]JP;EF,D X!6?)TZ!]D[X(VFSHSU+O@GLIV8
MSI6T4M?<K/DZ=L?T+O@@I\[O@N')7V4[+3I6#;<4T<^Y6O)T[V+O@H--G0<H
M3CQ&2>RDQG2NPN9$TX;BUPX*S/5*<GFAD[.1HS6^BUSR0.:&FSFZ X<EQ%-G
MNQ=\%/93LQG2MH@-SN1WKG8<%8\FS@'V+GW\!90*?.]B[X*QR4[7&8_2O8"V
M297-PK'D^=[)WP3R?.Y_H7?!7V4[2TZ5M@V)8%633YVUA!=\% IL\!G!=\%F
M>2C9:K2OD@MXKO\ )L]N@N^"D4V=M?4N^">VG:6JTKV'!38<%WBFSEOLG?!<
MA3IW;JG>.2OLIVL4SI6 '!  #L*L^3IWL7?!/)T]G^B=\$SIVMITKV%C<*+!
M6/)T[V3O@I\GSG9.^"OLHV8SI7 'M4&UMBL"G3O9.^"GR?.G]T[X)[*=F,Z5
M;#O2PX%6O)L];[)WP04V=M]B[X*>RG;.,Z5M&Q-@@ V65D4V= ^R=\$%-G<S
MJG?!/93M<9TK6 VA<2!N*M>3ITC[%WP0TR=[%WP4FNDM.G3)C]<E[']XW^ZR
M/&5M3) DWU+/Q7CRE-G>NR_Z!UA$:=W%>[BR6C1V2K(#"YS(;0X<#GQ4CDHV
MN-7PQ*PO92T!6?)L[?[%WP7+R;.]D?@K')3MC"=*UA=0 ."LFG3@M^B=W[%/
MDZ=W0G?!:]E#>,Z5K#.P4!HWA613YW/]$[X(*=.]D[X*9T[,9TK>C8C2!'J[
M5ZD+$M;A-T(%5G(3!]UL9P_%5#39TC*$[X*!2YP"^H<3[%F:Z)9FFK3E.U"<
MGG STU&F"!D8CRZW-5@."L>39W8(+O@I%.GNQ=;V+5/)3'[6(G2L;;PF5E8=
M39TG[%WP4&G3O8N/)2>6G9:=*]@F7<K(IL[MU+O@H\FSMLH+K^Q/;3LM5IT
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M*1(P;?9CFK9%TME:Y3.I<*53J,'LQS4=2@W'Z,<U<MWE0!WE,ZC"E5ZC!O\
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M6?=#&/6UZF"ES\0-JLN2UP.5[E[A_I 0>[C7%L[AZ8@PX4HV,V(X-!L3MO\
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M#8YK@TC3<!8^%ENV@T:0HLJ8-,EF2\$_<9LVG\RKL.6@0XKHL.##;$=Z3@T
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M09DBZ(DS!AN(='AAWJEPNNN;FV2\G$F"\%K1Q'%!;189@+&C<4=9NV#!U):
M [SC>^Z_<LMBQV003%B,8/YG60=R+IAQV1@=3%AO'%K@;+B^8A,=HQ(S&/&Y
MS@$2ZPB\/$]?A46C1IXED0L!(#3>^1/'N73@O$<+$-*ZT"QC],MT <]@.R_>
MBLB15XTU#9DZ(R'_ %N *Z8DZUL&*]KP8<-I=I@W!L+H+R+#<-8UA5BJ34H[
M50A!>Y@<76+K&W%7*C7IR5Q#!DH4J(LL\7U@!)]&_@@R9%T.C!K=**]D,;M(
MV1L=CR-5%9$)X.!"#O1$0$1$!$1 1$0$1$!$7$DZ1&[B@Y(NIT1L-I,1X:T;
MW&RZ^L0WL?J8\-[N <#9!91:TP/B:?GL43\I49J\"& 6AQ  \VZV)!CPXC28
M<5L0#:6D%!WHNETQ#AMO%>Q@_F-DA3$**;PHK']S7 V0=R+IU\-H(=%AZ0W%
MP7%DQ#BWU<5CG-V@.!06$72V9@O.BV-#+N <+I$C-A,+WFS1O=D@[D5=DY >
MYH9'A.<=P>+KM#BZ^T60<T76(T/3#71&!Y^Z7"Z1'AANYS6M_F-D'8BKOF84
M*VLBM =L)(LN4&.R(XM9$8_^EUT'<B*'.#1<D#Q*"45?K4)I<'1X-^!>%3KD
MV^#0JE,2T0:<*6B1&O:;V(:2$'J(L Z(Z]/5ZC1X\_'B1HK(KFC2ML ;^:S8
M3DOIZ)F(6GPTP@LHNHO-@=G'@N'7(!N&QX!?PTQM06$58QM$#2<T<238>Q2V
M:@NBV;&AOOL#7 H+"+7'2-B*I4FKTV')1C"@Q(K6/ ^]Z7Y!9Y+3<)T""7QX
M0<YC207B^Q!;1<-(-N2[S>)V+J$W!+K:Z%:]O3""PBX-<'$V)LN1-AN02B\R
M7K4G,5!\E">3&9MV6W=_>O2N-E\T$HNI\0,/G.:&^*X";@.BB&V.QSSG9K@4
M%A%K")BBI0^D:)33,WDVD79?(#6$?V"V/#FH42VKBPW./W=(706$73'C-@L#
MXSPP7MM7%DU">X-A18;W$7MI!!81=,288R(UA(TCWKB)F#$B!D.,UQWZ!!06
M$71UJ '%ICP]*]K:0NN9> ";Y#>=B#L15Q.2]P!'AD\-(77<PAPN#<(.2(B
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MWG!EN&]!<QQA>1?@&+%E*W5IB$UA+7NF;Z7F.V^:NOH7PG"92!.MJ56TVQ2
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MT3$S(3HDC)D&*;B]@_2.6W8T[D%[%^#)K"='\LTRO5J/'E@'161YLN9< DV
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M-7T<FDC@JC].&!/_ +BEMFT+=L'8%J_".%ZC(UN!'FH.@QIO?2:?[%;1&8)
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MK" [F%.OJG\.[F%[X &Y#8*_2,>ZQ4R?V=_,+D)BIW/ZNZP[PO?O?9M07MF
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MD1ZK:_5W6\0O?-B@L$+O $:J'9+NYA0(]4(^P=S"R&PO=1D">*A=X CU3/\
M5W<P@CU0_P"7=S"R#+-0+7R0N\#7U0?Y=W,*!'JG\.[F%D)4960NQ_7U//\
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MHEHR)[U\/^2_V0\GD_HWFZ<$^\4N OG/*62UB@NFW>@*2-ZC--R!WH+_ /\
M*#>@S02A]BBXW(/[(!";DWH@C=O4@J+W*GVH");*_%2@;<DM8%-OBH02#Q4!
M%/%!'-2.Y0,U.P((]B(IVH(%O%.*';M^"D!!&6]-R>Q$ %#M0$(B'$H%.W8H
M[D4%U.[)-H2R"!L0(/@B!9 @V*0<N*"+[D4*1F@D[UQ;LS4G)2<ALR00$O=
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MJ#@6DT>8U\M#O%M8&YRS!X]RRL !H'!2 !N3;N4:2-B(BBB(B B(@(B("(B
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MK3*WALR[XD)@:84P7:.S1R#1WG>O9P!C5U?AQX=6@PI6?@V+PP%K;&Y&TD[
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M>'L&OI>()FINFF/$4N.@ 1:[@[\%F6UN8N5'G7)<+!!A%5P4ZH8R97>MPP&
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(!$1 1$0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g845594g79r23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845594g79r23.jpg
M_]C_X  02D9)1@ ! 0$ BP"+  #_[20X4&AO=&]S:&]P(#,N,  X0DE-! 0
M     "4< 5H  QLE1QP"   "   < E  $51U<&EK:6XL($QA;F-E(%,N #A"
M24T$)0      $*2'['VF0Q+BDE7$--&0N6$X0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q 86?<          IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ "+/M\
M 0 " (L^WP !  (X0DE-!"8       X             /X   #A"24T$#0
M    !    '@X0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      S4    &              %U   ![0         !
M                          $              >T   %U
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   %U     %)G:'1L
M;VYG   ![0    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   !=0    !29VAT;&]N9P   >T    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!$       $! #A"24T$%       !     ,X0DE-! P
M    &=P    !    H    'D   '@  #BX   &<  &  !_]C_X@Q824-#7U!2
M3T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A
M8W-P35-&5     !)14,@<U)'0@               0  ]M8  0    #3+4A0
M("
M     !%C<')T   !4    #-D97-C   !A    &QW='!T   !\    !1B:W!T
M   "!    !1R6%E:   "&    !1G6%E:   "+    !1B6%E:   "0    !1D
M;6YD   "5    '!D;61D   "Q    (AV=65D   #3    (9V:65W   #U
M "1L=6UI   #^    !1M96%S   $#    "1T96-H   $,     QR5%)#   $
M/   " QG5%)#   $/   " QB5%)#   $/   " QT97AT     $-O<'ER:6=H
M=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P
M   2<U)'0B!)14,V,3DV-BTR+C$              !)S4D="($E%0S8Q.38V
M+3(N,0
M            6%E:(        /-1  $    !%LQ865H@
M     %A96B        !OH@  ./4   .06%E:(        &*9  "WA0  &-I8
M65H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W
M+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC:
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M<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X (P H "T
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M.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^)
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M3%E3M"TC@_R7?N6,738>6+6M:7;]WT'^/?:\?FV*)8VTDDQ( ))@#4DI*42
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M $:L?4_^<RQ_P='_ */7!YH_]>)U+_PQ_P"BZDE/K&!G4Y^.,BEKFL+G-AX
M,M.QWT2Y65D?5?\ Y)'_ !MO_GQRUTE*22224I))))2DDDDE*22224I))))3
M_]3U5))))2DDDDE*7E?^-%S!]:^FAQ _51_Y]>O2NI69-.'9?B@.MI'J>F=
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M?O-_PB9.1B+$>+N$$TEZUF68V%8ZAAM>TM]0-U+*S]*US?I;?:L-F;33<,_
MM8W(< +L29]9O@*V;W^I^X[9_P"DU8Q?1MV^M8^UX^@ZUY+/ZCZ*_2H=6[_B
MT7&Z!LS6WX9&+AN)-^.T1#A^;CN9[?0L_P# OS/^!A$_<(,=?^Y_K+#<B"/]
M[Q=C"S*<W';D4R&ND%KA#FN!VO8X?O-<JG7.M5]*QP8WY%LBFLS&D;K+-O\
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M!ILW[_\ 3?H_TJCB_4S'QK@^O(<QDM)%3159[:LO#8QF30YEM=55.97Z+/\
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M &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ',
M: !O '  ( !# %, -@    $ .$))300B      %.34T *@    @ " $2  ,
M   !  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q
M  (    >    ?@$R  (    4    G $[  (    2    L(=I  0    !
MQ    /    "+     0   (L    !061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD ,C R-#HP.#HP-B P,SHQ.3HR-@!4=7!I:VEN+"!,86YC92!3+@
M   #H $  P    '__P  H ( !     $   'MH , !     $   %U
M  8! P #     0 &   !&@ %     0   3X!&P %     0   48!*  #
M 0 "   " 0 $     0   4X" @ $     0              2     $   !(
M     3A"24T#_0      "           _^$!5D5X:68  $U- "H    (  @!
M$@ #     0 !   !&@ %     0   &X!&P %     0   '8!*  #     0 "
M   !,0 "    '@   'X!,@ "    %    )P!.P "    $@   +"':0 $
M 0   ,0   #P    BP    $   "+     4%D;V)E(%!H;W1O<VAO<"!#4S8@
M*%=I;F1O=W,I #(P,C0Z,#@Z,#8@,#,Z,3DZ,C8 5'5P:6MI;BP@3&%N8V4@
M4RX      Z !  ,    !__\  * "  0    !   ![: #  0    !   !=0
M       & 0,  P    $ !@   1H !0    $   $^ 1L !0    $   %& 2@
M P    $  @   @$ !     $   %. @( !     $              $@    !
M    2     '_X3]':'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP
M86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y
M9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM
M<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O
M,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D
M9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS
M(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+R(^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(T+3 X+3 V5# S.C$V
M.C4W*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A
M=&]R5&]O;#Y-:6-R;W-O9G3"KB!7;W)D(#(P,38\+WAM<#I#<F5A=&]R5&]O
M;#X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C0M,#@M,#94,#,Z,3DZ
M,C8K,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D
M871A1&%T93XR,#(T+3 X+3 V5# S.C$Y.C(V*S U.C,P/"]X;7 Z365T861A
M=&%$871E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F
M/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY-:6-R;W-O9G3"KB!7;W)D(#(P,38\+W!D9CI0<F]D=6-E
M<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P
M.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIC
M<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @
M/')D9CIL:3Y4=7!I:VEN+"!,86YC92!3+CPO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @
M/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT
M(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \>&UP
M34TZ26YS=&%N8V5)1#YX;7 N:6ED.C<W-#)!,3DU-S0U,T5&,3%".3$X1D8T
M1D8P1#1#,S V/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ
M1&]C=6UE;G1)1#YX;7 N9&ED.C=$1#(R-S1%-3,U,45&,3%".3$X1D8T1D8P
M1#1#,S V/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I
M9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-T1$,C(W-$4U,S4Q148Q,4(Y,3A&
M1C1&1C!$-$,S,#8\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @
M(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.C=$1#(R-S1%-3,U,45&,3%".3$X1D8T1D8P1#1#,S V/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(T+3 X+3 V5# S.C$Y.C(R*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-S8T,D$Q.34W
M-#4S148Q,4(Y,3A&1C1&1C!$-$,S,#8\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C0M,#@M,#94,#,Z,3DZ
M,C8K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L
M:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T
M179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.C<W-#)!,3DU-S0U,T5&,3%".3$X1D8T1D8P1#1#,S V/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(T+3 X+3 V5# S.C$Y.C(V*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E
M<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ
M1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C<V-#)!,3DU-S0U,T5&
M,3%".3$X1D8T1D8P1#1#,S V/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @
M(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.C=$1#(R-S1%-3,U,45&
M,3%".3$X1D8T1D8P1#1#,S V/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @
M(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-T1$,C(W
M-$4U,S4Q148Q,4(Y,3A&1C1&1C!$-$,S,#8\+W-T4F5F.F]R:6=I;F%L1&]C
M=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @
M/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP:&]T
M;W-H;W Z0V]L;W)-;V1E/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@
M96YD/2)W(C\^_]L 0P &! 4&!00&!@4&!P<&" H0"@H)"0H4#@\,$!<4&!@7
M%!86&ATE'QH;(QP6%B L(",F)RDJ*1D?+3 M*# E*"DH_]L 0P$'!P<*" H3
M"@H3*!H6&B@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H_\  $0@#) 0F P$B  (1 0,1 ?_$ !T  0 !!0$! 0
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M0
M               #>#RY;;=2-BJDGT>Y3G2>_L/#DHMK#];-+<<2Z?;ZQ3TZ
M4U*O-9PI1>/.Y?'/4F*S/I/&9]-^  @
M
M'> .6=O2K2X;?D*TZ3S%\T>OIHZBY;XR0+M<MW<:/B*RMOYD68?WAU3VA795
MVBR5:&E:U-J<WBG-MRRVV]_ [;;5H58J4)*65E/U'R'>V$IQ\HI>3K0WB\9W
M.G=DW'_DY0TG6)M26>2<FMWF,4L)>TTYO'_U5??'ON'=&]\%,O/4LT:T*E.-
M3FS&2RF7GONC%IFF-/2W!2!40
M                                !O"!26%C/S 4;7*>);+=B<E!\TG[
M"+\:\66O#6GUJ]6JG6?H0Z-X:SOA^)-:3:=0F*S/IK>TWC6WX=TRK3I5,WM6
M+C34<]<96ZZ'&> [VYU;M I:AJ52;E-^:F\]:B?ULCUS5NM>U:IJ%W4<EG,(
MM+N?BL$SX!LV]:MISCC$XX]G-$]''BBE)VU4K%8[?2:W0*0]%%3S60
M
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MSZT]@ E
M          'E]4\] /65XH\3:Y=M\"26?::3BC7+3A_3*UW<58\RC+EAE9;2
M;QC/J$1-IU!$;G3'XRXFM.']+G7N:M+G:Q&#G%/?U-GS3K&H7G$FJN[O)2\E
M*681W2Z8?J[C.XMUZ[XMU>I7J.2L82:C2;>'OE>:VS)TK375E#$?-_-CCIU/
M3\?%&.-S[;,58K'9HFFNHHXA+*?3#.G<(:1&WKT*U6+3VQE8\#%T+1Z=O352
M:6?6D;CW=&E<4*<'MSQ7[SG+DWN(<9;?QT>FUR+='HQ[5\]O3?BC(/.9P !
M @
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MZGD'B&VR/8 !=
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M#FM=QV^E-*ES6-%^,49AI^&6Y:#8/QI(W!YC-( "$"Z
M
M        !1]&5!$CQ'J<Q[>*OD^'L_H_SHZAA'(ONB:GD^%\YP\Q_GB6^/\
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MO3OJ[BI@V-W"\HPJT)YIR2:9DOG:PNGCDP3TS3&ET%(9Y5D;DH5 0
M                                           #Q %J;\_'AN7.G>6+
MFM3I4YU*CY8P7-)^H@UMCZG=T;*A.YN*ODZ4(-O,DNF7W^PX-VD<95]?NIV.
MG3G&T@\.2;7-T:W4FGT,_M2XS>IW,]-TZI.-&$N6;BVLM.47M[&B(:1ILL02
M\[F_.\3?@PZ^5FO#2(CMZTO2FX4X4UF2?SO?V'1- T>-*$:U:*C))+EQCPWQ
M@IH&C*ARU*D8MKO:7B;34KN%.GB+PUML67OOXU+V^H>=0O(6]+DAM@BNHWV5
M)N6_M*ZI?<TI/F9%M0O?2\YG>/',>TTK_2_O=WN:"YO>6ZI23Z33_>>+R[RW
MYS-/7K_?HR;RD\_O-<4^*[6H?7? 5P[GA739OOHQ?\211>40SLMN8W'!>F.#
MZ4(?63)>DSP+_&9>?:'H! YAR  D
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ML,HPM,OJ-[;4ZMO4C.$EE.+3QN9/-S2:6[\>XP:TSS&EQ>H'F.5UZGH  @
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M4Z27_4=<CWK8\#-W:6*RJZ (=Q7ZAP )@F  R     ,
M                                               IG$6Y;8 J#75M
M:L*-1TYW"519\WEE]ACSXETR"S*YBO\ EE]A,5F?28B9;D&B?%>D*#E[KCA?
M\$OL+7^F&DOI=1?_ "R^P<9_B>,I$",RXRTU2Q&K%_-+[#S/C&S3Q%Q?[7V'
M48[3]'&4H!&5Q;;-92B_G?V&10XAA62:IQP^F[^P?CLCC+?'EOSC0W.O2I+S
M::?_ #?Y&JO>**\%][HI/]+_ "$8YDB$QEM(Y=]T!HM[JW"4WIM/GKP<?-\?
M/CGIZC(NN,[VC)-TLQ_3_P B4<.:_3U>@XR:57XN^_7U'44M2>6DUB8G;XFI
M^5I/EJTW3K_G1::V[C)C4SZ/H_6?0?:[V6TKZG4U/1(.-W!9E2@EYV$DMY2/
MG3%2WO*MK<P\E7IYS#.>CQG*/2Q>16VHB6F+PSJ<V9UO7:6,LU<)>;DO0DUA
MFNMOZMB4GLKK"6YO].O<)9;^D@UO6QWFWLKEK&XM2)==.C6%]F.TG])*=,U#
M*Y9/]_K.76%ZT233[YY6#%DQSKXJ[5WZ3?4=/HWUNY4U'GQX+P9 =>T5TIRE
M*/GKHTB8Z5J&R-G<VM+4*#;BG(JK::_LK[CVA/ W&%SH%TJ&H2G*V>%F4I2Q
MC+Z9QWG<M*OZ%_;1K6TXRA+O3W.#Z]HG(ZBK;P?1/YO6;WLD>JT;UT9<[LL^
MCF..N_K*\]*S\H1>L3'3M,4]\L](\P?FK8]&-FT) )Y
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MWC9*1NT'"8=J]H,:S\M&E'R[;F_$R2AR
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M\Z]]LLW5CG"]@;:[C3ZUJ+MUR4<.37-_'UGC0]9A<?>JWFU/%[+O\65PY;Q
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M)U-DL.4DMLM](F[Q_(BW[2NB[41J<L=GNR]2KNG+=]372N*?DTU);=2:=G'
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MSJ/2F]N^B"6-DD^\]'A<SEGHEM@]LS:5F4#SAY/0
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MJ\MI.3G#,9+O6QG:'J\J4O(74F_!O+\6!*%ZRIYC*,DFGE,]
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M0]'BDVV_B]Q[,JJ  !(
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MVF<M%S2]2E9R5.MZ# E6_+E+=GHMTJL:M)3IO*9<
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M_D3DZA-KO2BDFD5Y<I(I'+/70R./8N@ )
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M(@D'+RLX-.+BVFGMT/HFK"-6FXSW@^J\3G7&_"$<3OM.7*X^=**[\<S>[?L
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M(F-IAY<$TT]T'!-=6>@-"B6.\JT  0
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M@AYM*#RY/!G%(Q45A%0D
M
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MLD>J45C)<;Y5B/5E.917+WERUI2ES.73N"'JWH-OFDMC-2PL(I%86"H2
M
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MY5MU\"L9<JPBY2INI++6P"WHNH^>2P9T%RK&.A2G%0C@]
M
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M1Y.46XM="]2AN!6E#)?IK&2B6%ZR[0@ZC I2CY2HT9\(J,<(I""BL(]
M
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M4!       QJUM&6\4LF(X.)M"U4I)]$@,.G3<S.HTU""6-Q3IJ*Z'L
M
M
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MB3:E\''V >@%T
M
M                                         #0\;?D_=?H?6C?&BXV_
M)^Z_0^M <3AZ<O:R[ LP].?M9=@]P,NAZ1L[7H:NAZ1M+7I\X&ZT[JB4V'HD
M6T[:2)5I_0#5ZEU1*](_ 8>SZB+:G';J2G2/P&']=P&8  ! >U;\"I?I1_O$
M^(#VK?@5']*/]X#FM'H7X%BF7H 9EMU1MK8U-MU-K;/H2)!I7<2%? /V$=TM
M]"1+X!^P#3K\.A^DOXDVI?!Q]A"XQ_VZ&_YR_B32E\''V$#TN@"Z
M
M
M                    !H>-OR?NOT/K1OC0\;?D_=?H?6@.)P].?M9<IEN'
MIS]K+M/* RJ'4VEKT1JZ&TC9VKV W5AZ2)5I_0BM@UE$JT]IH# U3T42?2/P
M&'L^HC&J+S42?2/P&'L^H#,   @/:M^!4?TH_P!XGQ >U?\  J/Z4?[P'-:?
M0O4RQ3>Q>IL#,MO2-K;=QJK9[FUMGT]A(W^E_F_UXDCC\ _81O2WT_KQ))#>
M@\> &J7X;#])?Q)G2^#C["&)8OH?I+^),Z7P<?80/0"
M
M
M           #0\;?D_=?H?6C?&AXV_)^Z_0^M <3@USR]K+T.A9CZ<\%ZF!D
M4>IL[4UE+TMNAL[4#<6/I(EFF]")V'I(E>G= ,/5/11)M(_ 8>SZB,ZGZ*)-
MI'X##^NY 9@  $![5OP*C^E'^\3X@/:O^!4?TH_W@.:4R]3+-/H7J?0#+MO2
M-K;[8]AJ[9[]39VW<2-_I?=_7B26D_O+]A&M,?3^O$DM+X%^P$-6_P .A^DO
MXDRI?!Q(;C_;H?I+^),J7P<?80/4>@"
M
M                                                           #
M0\;?D_=?H?6C?&AXV_)^Z_0^M <3AZ<O:R[31:AZ<_G+U,#(H]396IK:.\C9
M6O<!N;#TD2O3>A$[#TD2S3%L!BZGZ*))I'X##^NXC>I^B232/P&']=R S
M(#VK?@5']*/]XGQ >U;\"H_I1_O <TIEZF6:9=I@9=MZ1M;;N-7;=3:6_<2-
M]IGYI):/P)&M,[B2T?@7[ -<_P -A^DOXDPI?!Q]A#W^&P_27\284O@X^P@>
MET CN@
M
M                                  T7&WY/7?Z'UHWIHN-?R>N_T/K0
M'#X?"R]K,BGDQX?"R]IDTP,BEU-E:FMH]396P&WL?21*],V1%+'TD2O2P+.H
M^@B1Z3^!0_KN(YJ/H$CTG\"A_7<!E@  0'M7_ :7Z4?[Q/B =J_X#2_2C_>
MYG2Z%Z!:H]"]3Z@9=MU-K;]QJK;J;6V[@-YIW5$EH? OV$9T[JB3T/@7[ ,#
M_P",A^DOXDOI_!HB#_#(?I+^)+Z?H(#T
M
M
M &BXU_)Z[_0^M&]-%QK^3UW^A]: X?'X27M9D4C'A\)/VLR*8&12ZFRM.GSF
MMI]<&QM.@&XL?21*M,(K8]42O3-V!;U/X,D6D_@4/9]1'=3^#)#I/X%#^NX#
M,   @/:O^ TOTH_WB?$ [6/P&E^E'^\!S2ET+T$6*70OP RK=[FTMN[KT-7;
M]3:6W<!O--ZKJ2BV^!?L(OIO5?UXDHMO@6!@R_#:?Z2_B2ZEZ"(C+\-I_I+^
M)+J?H(#T
M
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MI1W[C#EIE+RJFLY1G12BDEW 575[@=X
M
M                                                           ,
M;L  UGO   YOVJI>^?#N5G_;Z?\ !G2#G':K^,^'/_J%/^# G]@O]AM\[_>X
M_P #(22Z%BP_ ;?]7'^!?      "6V'N$L=     ICSLG+[5M=K5/]&XV^=G
M43EMK_[VH?HW'\6!U(8
M
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MHFM^[!RZGVBW-34J%"=&$5-I>;&7>\?&.FV]3RM",W%+F6<8 N@+JP
M
M
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M3=K3P^X^>*/X]L_UD?YCZ(LOP6G[ +R6.KR
M
M
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M]A\ZV_X^L_UD?YCZ*LOP6G[ +P
M
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M_F/HVQ_!*7L O
M
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M\Q]'V/X)2]@%X
M
M                                          -1Q?\ DW?_ *OZT;<U
M'%_Y-ZA^K^M ? >J?C:]_7S_ )F8\?2,C5/QK>_KY_S,QX^DP-KIWPB_KQ)O
MH:\Z/M(3IR^^+^O$G&AK>/M G>F_ KV?8;&'4P-.7WF/L,Z/4#3ZO\-$^@^$
MOQ#:?JX_RH^>]7?WZ)]"<)?B&T_5Q_E0&W   @W;1^05][)?]N9.2#=M'Y!7
MWLE_VY@?#D?1/=#J>(]#W0Z@;S2_A8_-_%$[T-;Q]B(+I7PL/:OXD[T3K'V
M3>S^"1?CZ,BQ9_!(OKT) :RU_']I^MC_ #'TA8_@E+V'S;:M_P"D%FN[RL?Y
MCZ2L?P2E[ +P
M
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M7L O
M
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MR/\ .?25E)>Y8>I 9 ">6
M
M                                             4YEC.5@"H*<R\2O
M< -#QG4ITN%]0G4ER05/=XSWHWDIQC'F<DH^)R'B/4:O'.OPTC35S:>FE.NE
MF*37BO6@/DS5ZCEJMW)S:2JSDGCJN9F+3JYEG.<]Y]\6'!^F6MM3I2A-N*2;
MYWN\&5_HQIN?@ZG[; ^%M.G'RB;?[O:3K0I1;BX[K/4^L5PYIT>E.?[;+T-#
MLHO*A//Z0' ["4/(K*[C*YER/EZ=YWA:9;)849?25][;?&$GCV@?-FKPC<W<
M8TUN_L/HGA5-:%:1?54XK_I1D>]=MSJ7++*_XC-C'EPEZ*6$!4 ,#RL26? @
MO;7G_0&]Y=WB3^;R<R=8V6SZEF\M:=Y1=&LFX9[G@#\Z%4VZEVA-)[L^_EPO
MIB_W=3]MGK_1C3?_ ,NI^VP/AW1JD547G?N]:)_H4XYB_*/IX>H^I8<.:?#I
M3G^VR_3T>UI^C&7[0'!K6<?)KO7B793BJ<MCO+TVW;SRR^D/3K=K'++Z0/FV
MV<'Q!9<VV*T)<WJYSZ5MIPE9PGGFIM=<$>XMX4M]7TJI;TLPJ>E&3;QG#POW
MD!X2XFN>#=3AH/$,?)6R;C"M)*$7&,7OOOUP!V==ZQL5+=*K"K%3A-2A+HT7
M,K&0 ">5E="BDFDT\I@5 RLXSN
M
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MF6=T].X4D5 )B  !(
M
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M&V<>!Z/1]-T0-E3S(]$H@  2
M
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M_P 6;?#C39XT:JV>%S>L]%/SBIZ$M1A>
M
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MD'MJ"6%@EW"\W3;I/O\ \ST/'C4MN/I)>_)4HGNT5-LKP
M
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M+=OU(GM-IQZFC%?G':Z)V]9*E,E2QT  !DIDJ"-@MP 2!1/)4$  "0
M
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MU1S-H@74]O JC6WNIT;:#<IYFNB6YYTFZKW5:52:Q2Y=EZ\G,9(F=#:  L
M                                        /=   !1O&>]^ ;VR1#M,
MXPAP;H-2_<(5*NW)"6=_.BGT?_$<LX.[<KC4]?MK*[M:4*5Q5C3YO.VR_6P/
MH/(3+5O5C6HTZD,8G%26/!ES.[3 9WP5;P>()))-N3\653P\2Z@>BG/'?SEM
MZS'OKNE96\JURVJ:?=N1OACCC1>)+VM::;4E*K#ESF..J;\?4P)9G=K#V[QE
M>)IN,;RXT_AO4+FRBY7%*A.<$L[M1;70X_V5<=<4:QQ1=6VK6LU;1C/E<N=]
M)12Z^IL#O*>4F53V/&'SQQZ)ZQGO J,[]#CG:GVKU.$=9A94:"J-QB]U+O<O
M!^HB=/MZU/EYY:2W3>ZDJ=1[?2!]'YZE.99:RLKN.7\ ]KNF\45Z="450K5.
MYQ<?'Q?J-[VF<7?Z(:13OJ=*%653F7G9[HY[@)H,GS;2[>]5K.52VTN%2$98
M>(U']9LM/^Z"BKA1U/3O<\7U:I3\/6_8!W^,LC*3PWN:7ACB.PX@M76L:L9-
M>DOG:\?4;G;/G8SW >D\YV&=LLI%O?*Z/8UFO:W8:):RN-1KJG3BLM967NN[
MYT!LE+*;P]BJ>3Y[U_MY_P#2D;;2;=2H\R3E*,H_P9W#AO4'JFCV5W*/+*K0
MA-^UQ3^L#:@                          6[BE&K2E&2RFFL%P 0G6-.N
M[&;N;*3IP7YJ2]G>SQ8<4M17NF#]KE_D3.O3C.#4MT0CB+094JDKFC%\JWQ\
MQYN>E\7>/M7:)KW"0VVO6=3ES62;QMA_89\-2M9+:LOH9RWF2GAY3]I<4WG:
M>/G,]//OZF.W$99^W4_=E#ERZBQ[&6YZC:16]9+YF<YIU9=/*="[3J-O&6RZ
M?/MKJ(3^5.:NKV\=J<N?Z5]1;6H^43VQ\Y$J=3NS@R8W=M;1YZ]Q""];.J>1
M:_[)B\MS=0E53?4T]U;X3<5B2>3!O./-$M%RSOJ%23Z1C+#--=\?W%WFGI&D
M7-?.RJ0<6OZZ'=XB?M$]SM.="U-TY*A53;QCKX?,2"K5I4J?-.24>^6#B56/
M&.K2:4/<=.7G9J4$\=^-C,T;A2ZO:W)KFHI^J/-#N?A[$68LDQU+JMM^V\[0
M;S0*UM.4KR$+J";BO)S;D\/"\$<AJ\01A5E"UM_=#65M/E_BCO6E\"Z):J$^
M2I5FGE-U9-?O*<3\(VE_8OW/14*L%YK7?C).7!6_SJXRXHGN' )76LWGG6].
M=O'U3C(S+70KVZEC4M1=5>$J2^IF[N[>XTZYE0N(\E2+PLK&12EF6TC!7+QG
M5F3G:O3(TGAS2K9YJ4*=27CAKP]9++"%K0BHT:45%+"2;V(Q;UW&HLFVMKE9
MZG<9)F>_2VF1*Z-:3CF.R,E<MU#DJ0YI?&;(_0KM--O8W&G\]S55.DGC/4U4
MON-+8G;#O-&JWE94Z*YHKN^=^LD_#F@4M.IMRI+RCQO]/K-II]M&WI)->?C<
MS4L'=,,<N2VM(CMY@GWK!Z -,.P    !XFF^XP[ZPA>4G"M!2BUC<SP<S7:-
M.*\5\+W&F74Z]*/-;N67A)866_'P1H*$(U)2Y5T.^WMK3NJ%2E4AS0DFG\ZP
M<ZU[A6=G7E6LX-TVVVMWC<PY?'BO<,E\$1W",6-NVE)>D;>E:0K+EK4E->MG
MJRMX]5LC:6U#EEGN*\>XDI5JKCA72+Z/WVRI^4QCF;;Q^\UW^KOR;<],OU0E
MW*-'./IEX$ZH4DNXMWMS&WB\,TQ/'NWI=.J^G/;J/%FCIIW5:_@_1CYE/E_C
MXFHN.,;NG"4=1L)0FN]UD_X+VDMU*_=1[RV?4V/"W#<]2N%6OJ/^SQ>4VL9:
M:^ILIF\Y+:JXBTWZ1O@W6M&OKN%6_OHT^N:;IREW>*1VG3+NSN:*5G44J?=A
M->/C\YIM1X.T:[@E7H-02QB,G%_2B%<0\#V=A!U-+O949=T95)2\/7ZV:(BF
M".Y[75K%*NA<1:O"QH.,-ZDEB.^,O'L(!<U)W5PZU3J^Y^W)#I6?$UJW.G=0
MN(QWY52RWZMR[3XCU6S6-0T^MMU?*D>;Y-YS3U*B^29Z2QQDWF'FFTLKVXM_
M.4G-?00^SXOTJI^&35"7A.9O[/4;"\25"_H3EX19GI6]/2*QI*[/B![*HFO^
M;_(VU#6*,NL_X_812-.KYJ<<PVWP;"A0WV-V+-E6Q:4GA?49Q]/]S*N[I+I(
MU%*'(MRU<5TLI,U1FFO<NIMTV-SJ=.":B\O^O4:#4M=J)-4XO/Z7^1AW]SB7
M+%YD_P#,O:-I-2XK>6K)\J[OI,]LU[SJ(<Q:9ZA<T/2ZMY55S=2YL[X:\-O'
MU$NM:;IO"6(I8%O3C!*,8X1D+9[=#7BQ:[6Q#'N;^VMGBO54'[&RS[\6.W^T
M+?\ X7]A?N+.E7EF:R_:6I:;;/\ ,?TFA+S[[V/RA?LO[![[V/RA?LO[#U[U
MVOQ'](]Z[7XC^D#S[[V/RA?LO["OOO8_*%^R_L*^]=K\1_2/>NU^(_I I[[V
M/RA?LO[![[V/RA?LO["OO7:_$?TCWKM?B/Z0//OO8_*%^R_L'OO8_*%^R_L/
M7O7:_$?TCWKM?B/Z0*>^]C\H7[+^P>^]C\H7[+^PK[UVOQ'](]Z[7XC^D#S[
M[V/RA?LO[![[V/RA?LO["OO7:_$?TCWLM/B/Z0*>^]C\H7[+^P>^]C\H7[+^
MP]>]EK\1_24]Z[7XC^D"GOO8_*%^R_L*^^]C\H7[+^PK[UVOQ'])3WKM?B/Z
M0*>^]C\H7[+^P>^]C\H7[+^PK[UVOQ'])7WKM?B/Z0//OO8_*%^R_L'OO8_*
M%^R_L/7O7:_$?TCWKM?B/Z0//OO8_*%^R_L*^^]C\H7[+^PK[UVOQ'](]Z[7
MXC^D#S[[V/RA?LO["OOO8_*%^R_L*^]=K\1_2/>NU^(_I I[[V/RA?LO["GO
MO8_*%^R_L/7O7:_$?TCWLM?B/Z0//OO8_*%^R_L'OO8_*%^R_L*^]=K\1_2/
M>NU^(_I I[[V/RA?LO[ ]8L5%ORZ_9?V%5I=K\1_24EI5K*$DHO+6.H&CO\
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ME:Z><+E:6<^)6&>C*E32[                !@
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M]3 78-H47'%6GC_]LO\ $9.B]B6BZ3JM&]HU:;G3DII>YDMTT_'U =9
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M].LZ=K1481C]'K9G16%T2]AOP88K\EE:Z4V^<K$J#2[&\(\Q>6>@
M                                      ><>=S9[L!I-YQD] #SAK&%
MLNXKC?.-RH HO44<%YWK/0 %O'=R;9SU+@ HGL\GCD4UB<>GK+@ \O+CX>HI
MGS=X]_3)[ %$]WX(+?=/8J /+SNN79^L]16$D@  ?J8 %-\=1NTL,J "]8
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M.,5%;&W!AU&Y65KI2,>5%8O**A&R.G8
M
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M'&6_6:O&P37<W64KKV\X2Z'I%.18QEE8K"-JPD\"+R@XIE8K"P$
M
M                                                        "C>"
MS<T8U:<HS68M8+[*8^@B8B8U(A6I\-.=TI6VT&VY+9=Y(M*L*5I24:22?L]I
MLVO ))="BOCTK.X<Q6(4BE%^T]%$MRIH=
M     *2Z'EK,=SVUE!;$3&Q&]<T=W4&Z;Q)+;VE[1-(IV=*,FEY7O?S(WKR^
M@2P4_@KO;F*QO:D4\9?4] %T==.@ $@
M
M
M                    %ZP&
M
M
M
M
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g845594g84l03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g845594g84l03.jpg
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M\?_:  P# 0 "$0,1 #\ E2
M
M
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MFGER,JIYX:F))*:6.6-=SXW(Y%[4/#DQ7Q]+QLL,>;'EC>EHE< !K;0
M
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MD>QKDS1')FFLBHO:B[4.0>++>+SO%=OT6&+';'&TVF?U  :FT
M
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M8]/UCFZ[_I+FIVX*S+JLN7Q66V'1X</@J  \[T@
M
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M-6NQ1Y6^F:DN63IG]]([M^Q,D.X *BU[7G>T[RNZ4K2.6L;0  Q9
M
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M8]-7:G?Y@ /,]0
M
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M8,%,%(I2.@ #4W
M
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M]*GS,O\ 9WKDR[6]R\R5+%^T#L@40S1S,UX9&2-YV.14*P
M
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M5>5-B]!OTD
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MVKL1=QKW[^6CO]XT_@ZC_P",RO'_ +!,2?-M3ZIQYX 3D^_EH[_>-/X.H_\
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M&-VJ^6-KN97(B@7 6>ZJ?]O%]-!W53_MXOIH!>      "VLT2*J+*Q%3D5R
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M>V6.1JY*QR+FBIVDQM%&G"R8HHZ>BQ!40VN^(B,<DJZL,Z^Z8Y=B*ON5[,Q
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M%&&)7*JJE&V+-?>*K/\ *9L2-$<,'V!V?YS;ZJ0B22VX8/L#L_SFWU4A$D@
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M\'K!-GQSBBXT%_9.^G@HUG8D4FHNMKL;OZG*:L-\<#WV=WGYM7UL8&U_^'C
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MWK6GH<3    :SX2%&VKT/7U7)FZ#B9F]"I*U/0JFS# -/GBAQ-\0WUC0((@
M@2:X&7XG%WPJ3^<23(V<#+\3B[X5)_.))DP!YLUWY;4?&.]*GI,>;-=^6U'Q
MCO2I L&U.#'XX;3\54>J<:K-J<&/QPVGXJH]4X";( )'0X_]@F)/FVI]4X\\
M#T/Q_P"P3$GS;4^J<>>! &^.![[.[S\VKZV,T.;XX'OL[O/S:OK8P):@ D
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MI*/Y3/\ 7(6DTN"UXI*/Y3/]<0-M@ D  ! W3KXV\3_*O\K3!#.].OC;Q/\
M*O\ *TP0@=_H^]GF&OG.F]:T]#CSQT?>SS#7SG3>M:>AQ,   !@&GSQ0XF^(
M;ZQIGY@&GSQ0XF^(;ZQH$$0 0)-<#+\3B[X5)_.))D;.!E^)Q=\*D_G$DR8
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M$SV)TDA@
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MX?KI-BYOI'.7EWN9]J=O057$]-SU]K7O'[+?AFHY+>RMVG]VX  <^OP
M              ##<5Z3<)83NOW-O]U[EK>+;+Q?<\K^]7/)<VM5.10-"X7_
M $NJKY;5>H>2L(9V'&-BI>$7/B>>NU;&ZJJ)$J>*>N;71.:U=7+6VJJ<A('[
M^>CS]X/_ &D_] &RP8)8-+>"K_=Z:UVF\\?75+E;%'W-*W67)5WJU$38BF=@
M13T)_I)8B^-K_6DK"*>A/])+$7QM?ZTDCBK%ECPI1I58AN=/11N\!'KF]_P6
MIFYW8@@=V#2=;PD\&P3*R"DO-2U%\-D#&HOTGHOF.XPYIZP/>IV025M1;)7K
MDWNZ+4;G\-%5J=JH!M0%,,C)HF2PO;)&]$<U[5S1R+N5%Y2H  6JJI@I*:2H
MJYHX((TUGR2N1K6ISJJ[$0"Z#4^(-/\ @>TSOAAJJJYO:N2K10ZS<_A.5J+U
MIF=;;^$C@RIF1E13W>C:OMY8&.:G7JO5?,!NH'3X8Q/9<44/=>'[E3UT";'+
M$[OF+S.:NUJ]:(=P  ,5M.D'#-WQ14X=M]RXV\4SY(Y:?B9&ZKHUR>FLK=5<
ME3G RH!RHU%5RHB)M55Y#7.)=-6![#.^GFO"5E0Q<G1T3%FR7X2=[YP-C Z/
M!6)Z#&&'J>]6E)THYW/:Q)FHUV;7*U<T15Y44[J62.&)TDSVQQM3-SG+DB)S
MJH%0-?W[3'@6RO='47^"HE;L5E&UT_G:BM\YC:<(S _&:O\ ^5R]UW,F7ULP
M-R PK"FE+!V*)V4]JO<'=3]C:>=%A>Y>9$<B:R]69FH  Z#&.,+'@ZB@J\1U
MO<=/-)Q4;N*>_-V2KEDU%7<B@=^#X[/<J2\VJEN-NEXZCJHTEADU5;K-7:BY
M+M3M,<QGI(PK@YRQWR[11U66:4T2+)+VM;N[<@,O!H]_"6P@V;4;;[VYF?AI
M#'EY.,S,SP?I<P;BJ=E/;[LV"L>N3:>K;Q+W+S)GWKEZ$55 ST   "W4SPTM
M/)/4RQPP1M5SY)'(UK43E55V(@%P&J,0Z?<#VB=\,-94W.1JY+W%#K-S^$Y6
MHO6BJ=70<)+!E1,C*BFO%(U5\.2!CD3KU7JOF W6#I<+8ILF*J):K#]RIZZ)
M,M9(W=\SH<U=K>U#N@ !BF$](6&<67.IM]@N7=593L626/B9&:K4<C57-S43
M>J 96   !C&,\>X<P9)2LQ)<>XW52.6%.)DDUD;EGX+5RWIO R<%%/*RH@CF
MB=K1R-1[5RRS14S0PW$^E+!^%[Q+:[Y=^YJZ)K7/C[GE?DCDS3:UJIN T1HJ
M_2COORNX?6<2L(9Z/\8V*U:>[MB.OKN*L\]16/CJ.*>NLCW.5JZJ)K;<TY"0
M/W\]'G[P?^TG_H(@;+!@^&M*V#<2WF"U66\=TU\^MQ<7<\K-;5:KEVN:B;D7
ME,X)&&VK1CA"TX@9>[?9F0W1DCI6SI-(JHYR*CER5V6W->0S(Q6V:0<,W/%4
M^&Z&Y<;>8'R,DI^)D3)6>$FLK=79ESF5  #Y[A6TMNI):JX5,-+2Q)F^69Z,
M8U.E5V(!] -27WA!8'MDSHJ>HK;DYJY*M)!WN?6]6HO9F?!;^$C@RIE1E33W
M>C:OMY8&N:GT7JOF W4#I<+XKL>*:1:C#]TIJZ-OA)&[OV?":O?-[4.Z  &'
MXTTE85P<_B;Y=8F5>6?<T2+++VM;X/;D!F -*_\ $E@OC-7N:\ZN?A]SLR^O
MF9;AC2]@G$4K(:*^0PU+MB0U:+ Y5YD5V2*O0BJ!GH"+FF:;4    431MFAD
MB>F;'M5JIT*1AJ(G03R1/\*-RL7K1<B4)'C'='W%BZZ199(LRRIU/[[[2XX1
M?:UJJ3C5-Z5O\NG^_1T(!PNXO7.J5*%*E*%#*%"E"E2E"AE"E2VI4I0H;(4J
M<P3R4U1'/ ]T<T3D>Q[5R5KD7-%0I4H4ALJDKHZQ;%BFSHZ16MN,&3:B--FW
MD<B<R^9=AE9%'#%^J\.WB&X4*]^S8]BKWLC>5J_[YB3.&;[1XBM,5?;WYL=L
M>Q?"C?RM7I0YO7Z/V%N:OAG[.CT6J]M7EMXH=J "O>X                ,
M(QAHLPGB^[_=._6^2HK.+;%KMJ)&)JIGDF351.53-P!"^Q8*L=7PAY\*STKW
M61M3/&D/&N1=5L3G-[[//>B<IOW[P>C[_M$_\9+_ %&IL+_I=57RVJ]0\E8!
MK[#NAW!F';U2W6TVV6*NI7*Z)ZU4CD1514W*[)=BJ;!  A5A_%\&!],.+[U/
M&LSXY:Z."+]I*Z;)J*O(G*O0BFQ,":([CC^I_M=I.K*F1:S*2&A:Y6.6-=J:
MR^T;EN:W)<N5#7F$,.0XHX1%705;$?2,NU543M7:CFQO>[57H541.TFHFQ,D
M(@8=1Z+\$4D"0Q86M+F(F6<M.DKOI.S7SF'XZT X5OE%*^QP)9;EDJQOA55B
M<O,YB[,O@Y+UFX02(IZ$L9WC1_CI^!<6.>VBDG[G8V1V:4TRKWJM7W#\TZ-J
M+SYRL(N<,"T,I+YAZ^4R:D]1')!(YNQ<XU:YB]??KY$)(87KW77#5IN#_"JZ
M2*=>MS$5?2!]5RKJ:V6^IKJ^9L%)3QNEED>NQK43-5(FWF\XGT]XS=:;,Y]'
MAVG=K:KLTCBCSV22Y>$]>1O8G*IG_"YQ-);\+VVP4SU:ZY2K+/DN^*/+)J]"
MN5%_NF<Z!\(Q83T=VYBQHVOKHVUE4[+:KGIFC5^"W).O/G ^+"6@W!5AI6-J
M;:V[5:)W\]=WZ.7H9X*)V*O2IW%VT38&N=.Z*?#-OB14R1U+'Q#DZ45F1G
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M!?W1TEQ7)K)=T4R_Y7=&Y>3F*#6<.G'[^+K'[+G3:R+^[?NVB "K>\
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M<B;'322-D5$ZD3;\) 29PW8K=ANS4]KLM,RFHH$R:QO*O*JKO55Y54 =F
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M539B*BIFBYH4.7#?%;EO&RTIDK>-ZR  U,P
M                 #0?##]AED^</Y;S?A@^EG1[!I$M%'05-PEH6TT_'H^.
M-'JY=56Y9*J<X'T:'?%;A7YOA^J9@=3A*RLP[AJV6>*9T[*&!D"2N;DKT:F6
M:IR';
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MM2>6T;2]M;1:-X  8I
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M;M2MJ;95P5<"^WA>CDZERW+T%5ET^3#/OQL]E,E;^&7V  TLP
M
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M>_%J*9.T]61@ \C>
M                                               :HTL8*UDEOEJC
M[Y.^JHFIOYY$^WR\YM<*F:9+N-^GSVP7YZM&HT]=12:61*4H4V?I0P*M ^6[
M6>'_ ))W?30L3\4O*Y$]SZ.K=K)3J,&:N>G/1RV;#?!>:76E0H4NJA0IN80M
MJ6U0NJA0J!G"VJ%"H7%0I5 RA:5"E4+BH4J@9Q*TJ%*H7%0I5 SB5I4*50NJ
MA2J!E$K61QD7%0X5 F)6LCC(N9'&09;J,CC5+F1QD$[J-4:I7D,@;J<CE$*L
MCE$"-U*(5Q.?%(U\3G,>U<T<U<E1>=%"(<HA"-VT,%Z7[I:D937UKKE2)L21
M5RF:G7[;MV])O##6)+5B2D6>T5;)D;X;-SV?":NU/01!1#Z[975=LK(ZJWU$
MM/4,7-LD;LE3_P"N@KM1P['EZTZ3]GJPZV^/I;K"98-/X%TO1U"QT>*6MAE7
M8VL8F3'?#;R=:;.A#;L,L<\3)89&21/3-KV+FCDYT5"BS:?)@G:\+7%FIEC>
MLJP :6T
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MK5WL<F]J]**<WK='.GG>/#*\TFJC/&T]X=D #PO8
M
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MU,_.U%\B&LT0[3#-4Z@Q#;:IBJBQ5$;EZM9,_,:-1BC+BM26S!EG'DBT)7
MY%U0
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M^Z'KS(S:GGR3M->6\4I-I\F6.LWO%8\Y22 !QSKP
M
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MY-F%%Q#71DCV6/MYRO>'Z*<<^UR=_*  %0MP
M
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M  >=Z
2                    ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
